Quiver News

Recent discussions on X about PepGen Inc. (PEPG) have been buzzing with activity following the company's latest announcements regarding its public stock offering and insider buying. Many users are highlighting a significant investment by a director, which has sparked curiosity about the potential for future growth in the biotechnology firm's stock. The conversation also touches on the firm's innovative approach to neuromuscular disease therapies, adding a layer of intrigue to the stock's trajectory.

Additionally, posts on X reflect varied reactions to analyst updates, with some noting a raised price target and a reaffirmed 'Buy' rating from a prominent firm, while others point to intraday volatility as a concern. The mix of optimism and caution creates a dynamic dialogue, as investors weigh the promise of PepGen's clinical developments against market fluctuations. This ongoing chatter keeps the stock in sharp focus for those tracking biotech opportunities.

Note: This discussion summary was generated from an AI condensation of post data.

PepGen Inc. Insider Trading Activity

PepGen Inc. insiders have traded $PEPG stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $PEPG stock by insiders over the last 6 months:

• CAPITAL MANAGEMENT, L.P. RA purchased 9,375,000 shares for an estimated $30,000,000
• SCIENCE ENTERPRISES PLC OXFORD purchased 200,000 shares for an estimated $640,000
• JAMES G MCARTHUR (President and CEO) has made 2 purchases buying 51,500 shares for an estimated $61,274 and 0 sales.
• PAUL STRECK (EVP, Head of R&D) purchased 8,375 shares for an estimated $10,393

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PepGen Inc. Hedge Fund Activity

We have seen 22 institutional investors add shares of PepGen Inc. stock to their portfolio, and 45 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SUVRETTA CAPITAL MANAGEMENT, LLC removed 1,360,932 shares (-81.9%) from their portfolio in Q2 2025, for an estimated $1,510,634
• DEERFIELD MANAGEMENT COMPANY, L.P. removed 953,626 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,058,524
• BLACKROCK, INC. removed 646,232 shares (-49.9%) from their portfolio in Q2 2025, for an estimated $717,317
• MILLENNIUM MANAGEMENT LLC added 476,180 shares (+46.1%) to their portfolio in Q2 2025, for an estimated $528,559
• STATE STREET CORP removed 250,963 shares (-78.4%) from their portfolio in Q2 2025, for an estimated $278,568
• PROSIGHT MANAGEMENT, LP added 243,980 shares (+inf%) to their portfolio in Q2 2025, for an estimated $270,817
• GEODE CAPITAL MANAGEMENT, LLC removed 182,797 shares (-47.6%) from their portfolio in Q2 2025, for an estimated $202,904

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PepGen Inc. Analyst Ratings

Wall Street analysts have issued reports on $PEPG in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wedbush issued a "Outperform" rating on 09/30/2025
• Stifel issued a "Buy" rating on 09/25/2025
• HC Wainwright & Co. issued a "Buy" rating on 09/25/2025
• Guggenheim issued a "Buy" rating on 09/24/2025

To track analyst ratings and price targets for PepGen Inc., check out Quiver Quantitative's $PEPG forecast page.

PepGen Inc. Price Targets

Multiple analysts have issued price targets for $PEPG recently. We have seen 5 analysts offer price targets for $PEPG in the last 6 months, with a median target of $8.0.

Here are some recent targets:

• Laura Chico from Wedbush set a target price of $8.0 on 09/30/2025
• Paul Matteis from Stifel set a target price of $12.0 on 09/25/2025
• Ananda Ghosh from HC Wainwright & Co. set a target price of $12.0 on 09/25/2025
• Debjit Chattopadhyay from Guggenheim set a target price of $6.0 on 09/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Microsoft (MSFT) have centered around the company's advancements in AI and cloud services, particularly with the Azure platform and new cybersecurity offerings. Many users express enthusiasm for the tech giant's strategic focus on generative AI, with some pointing to analyst upgrades and raised price targets as evidence of strong future growth potential. The buzz reflects a sense of optimism about Microsoft's ability to maintain its leadership position among major tech peers.

However, not all chatter is uniformly positive, as some voices on X highlight concerns over high capital expenditures and the pace at which AI-driven revenue will materialize. There’s a palpable tension between short-term spending concerns and long-term bullishness on initiatives like cybersecurity platforms. This dynamic has kept the conversation lively and multifaceted, as observers weigh the risks against the rewards of Microsoft's ambitious tech roadmap.

Note: This discussion summary was generated from an AI condensation of post data.

Microsoft Congressional Stock Trading

Members of Congress have traded $MSFT stock 47 times in the past 6 months. Of those trades, 29 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $MSFT stock by members of Congress over the last 6 months:

• REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $15,000 on 08/25.
• REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 08/14, 07/29, 04/07.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $65,000 on 08/05, 04/29 and 0 sales.
• REPRESENTATIVE CLEO FIELDS has traded it 12 times. They made 12 purchases worth up to $2,015,000 on 08/01, 07/29, 07/28, 07/16, 06/25, 06/03 and 0 sales.
• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
• SENATOR SHELLEY MOORE CAPITO has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 07/18, 06/18.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $65,000 on 07/16, 06/09 and 1 sale worth up to $15,000 on 06/11.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
• REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
• REPRESENTATIVE VAL T. HOYLE has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/09, 06/06 and 0 sales.
• REPRESENTATIVE JOHN W. ROSE sold up to $500,000 on 06/03.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/22, 05/21 and 0 sales.
• REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 05/13, 05/12.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $1,000,000 on 05/08 and 2 sales worth up to $1,500,000 on 05/12, 04/07.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 4 times. They made 4 purchases worth up to $95,000 on 05/09, 04/08, 04/03 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
• SENATOR JOHN BOOZMAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/22, 04/16 and 0 sales.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $50,000 on 04/21.
• SENATOR TOMMY TUBERVILLE sold up to $50,000 on 04/15.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE JONATHAN L. JACKSON sold up to $100,000 on 04/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Microsoft Insider Trading Activity

Microsoft insiders have traded $MSFT stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $MSFT stock by insiders over the last 6 months:

• SATYA NADELLA (Chief Executive Officer) has made 0 purchases and 6 sales selling 149,205 shares for an estimated $75,315,120.
• BRADFORD L SMITH (Vice Chair and President) has made 0 purchases and 3 sales selling 81,000 shares for an estimated $35,302,944.
• KATHLEEN T HOGAN (EVP, Strategy) sold 21,500 shares for an estimated $9,756,151
• JUDSON ALTHOFF (EVP, Chief Commercial Officer) has made 0 purchases and 2 sales selling 16,000 shares for an estimated $7,330,817.
• AMY COLEMAN (EVP, Chief Human Resources Off) sold 13,242 shares for an estimated $5,985,886
• TAKESHI NUMOTO (EVP, Chief Marketing Officer) has made 0 purchases and 4 sales selling 8,850 shares for an estimated $4,406,514.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Microsoft Hedge Fund Activity

We have seen 2,658 institutional investors add shares of Microsoft stock to their portfolio, and 2,677 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 90,533,328 shares (+564387.1%) to their portfolio in Q2 2025, for an estimated $45,032,182,680
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 52,343,132 shares (-84.1%) from their portfolio in Q2 2025, for an estimated $26,035,997,288
• GAMMA INVESTING LLC removed 46,539,719 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $23,149,321,627
• JPMORGAN CHASE & CO added 15,048,970 shares (+10.6%) to their portfolio in Q2 2025, for an estimated $7,485,508,167
• VANGUARD GROUP INC added 13,691,572 shares (+2.0%) to their portfolio in Q2 2025, for an estimated $6,810,324,828
• FMR LLC added 10,348,184 shares (+5.3%) to their portfolio in Q2 2025, for an estimated $5,147,290,203
• AMUNDI removed 7,227,353 shares (-18.4%) from their portfolio in Q2 2025, for an estimated $3,594,957,655

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Microsoft Government Contracts

We have seen $332,765,060 of award payments to $MSFT over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• MICROSOFT CONSULTING SERVICES (MCS) AND UNIFIED SUPPORT FOR THE U.S. NAVY / PROGRAM EXECUTIVE OFFICE DIGITA...: $34,962,543
• MICROSOFT AZURE STRATUS HSTXXX0000002144 93A34F: $28,200,657
• THE ENTERPRISE CLOUD MANAGEMENT AGENCY (ECMA) REQUIRES MICROSOFT AZURE CLOUD COMPUTING CAPABILITIES AT DEPA...: $22,878,989
• ARMY CYBER COMMANDS MICROSOFT CONSULTING SERVICES AND MICROSOFT PREMIER SUPPORT: $21,679,735
• MICROSOFT ENTERPRISE TECHNICAL SOLUTIONS SERVICES (METSS) MICROSOFT CONSULTING SERVICES (MCS) AND MICROSOFT...: $20,137,899

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Microsoft Analyst Ratings

Wall Street analysts have issued reports on $MSFT in the last several months. We have seen 26 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 09/26/2025
• Barclays issued a "Overweight" rating on 08/29/2025
• Truist Securities issued a "Buy" rating on 08/18/2025
• Cantor Fitzgerald issued a "Overweight" rating on 07/31/2025
• Stifel issued a "Buy" rating on 07/31/2025
• Jefferies issued a "Buy" rating on 07/31/2025
• Oppenheimer issued a "Outperform" rating on 07/31/2025

To track analyst ratings and price targets for Microsoft, check out Quiver Quantitative's $MSFT forecast page.

Microsoft Price Targets

Multiple analysts have issued price targets for $MSFT recently. We have seen 26 analysts offer price targets for $MSFT in the last 6 months, with a median target of $627.5.

Here are some recent targets:

• Keith Weiss from Morgan Stanley set a target price of $625.0 on 09/26/2025
• Raimo Lenschow from Barclays set a target price of $625.0 on 08/29/2025
• Terry Tillman from Truist Securities set a target price of $675.0 on 08/18/2025
• Andrew Marok from Raymond James set a target price of $630.0 on 07/31/2025
• Patrick Colville from Scotiabank set a target price of $650.0 on 07/31/2025
• Brad Sills from B of A Securities set a target price of $640.0 on 07/31/2025
• Jackson Ader from Keybanc set a target price of $630.0 on 07/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Recursion Pharmaceuticals (RXRX) have been animated, with much of the focus on the company’s latest milestone achievement of securing a $12.5 million payment from Rallybio for advancing a key drug candidate. Many participants are intrigued by the potential of Recursion’s AI-driven drug discovery platform, seeing it as a transformative force in the biotech sector. However, there are lingering concerns about the stock’s volatile price movements and the broader challenges facing early-stage biotech firms.

Additionally, posts on X have highlighted a mix of optimism and caution surrounding upcoming pipeline updates and the company’s expansive research efforts across oncology and rare diseases. Some users have pointed to the breadth of Recursion’s programs as a potential strength, while others remain wary of near-term risks in a tough funding environment for the industry. The conversation reflects a dynamic tension between long-term hope and short-term uncertainty.

Note: This discussion summary was generated from an AI condensation of post data.

Recursion Pharmaceuticals Insider Trading Activity

Recursion Pharmaceuticals insiders have traded $RXRX stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $RXRX stock by insiders over the last 6 months:

• CHRISTOPHER GIBSON (Chief Executive Officer) has made 0 purchases and 6 sales selling 918,175 shares for an estimated $4,694,964.
• NAJAT KHAN (Chief R&D Commercial Officer) sold 36,599 shares for an estimated $202,172

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Recursion Pharmaceuticals Hedge Fund Activity

We have seen 166 institutional investors add shares of Recursion Pharmaceuticals stock to their portfolio, and 147 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. added 4,864,474 shares (+20.7%) to their portfolio in Q2 2025, for an estimated $24,614,238
• VANGUARD GROUP INC added 3,783,201 shares (+11.7%) to their portfolio in Q2 2025, for an estimated $19,142,997
• STATE STREET CORP removed 1,905,719 shares (-14.6%) from their portfolio in Q2 2025, for an estimated $9,642,938
• ARK INVESTMENT MANAGEMENT LLC removed 1,826,871 shares (-5.2%) from their portfolio in Q2 2025, for an estimated $9,243,967
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,793,008 shares (-28.0%) from their portfolio in Q2 2025, for an estimated $9,072,620
• DIMENSIONAL FUND ADVISORS LP removed 1,682,722 shares (-98.0%) from their portfolio in Q2 2025, for an estimated $8,514,573
• LAURION CAPITAL MANAGEMENT LP removed 1,547,407 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $7,829,879

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Recursion Pharmaceuticals Analyst Ratings

Wall Street analysts have issued reports on $RXRX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 09/11/2025

To track analyst ratings and price targets for Recursion Pharmaceuticals, check out Quiver Quantitative's $RXRX forecast page.

Recursion Pharmaceuticals Price Targets

Multiple analysts have issued price targets for $RXRX recently. We have seen 2 analysts offer price targets for $RXRX in the last 6 months, with a median target of $6.5.

Here are some recent targets:

• Gil Blum from Needham set a target price of $8.0 on 09/11/2025
• Vikram Purohit from Morgan Stanley set a target price of $5.0 on 07/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Rolls-Royce Holdings (RR) have been lively, with much of the focus on the company's strong year-to-date performance and analyst upgrades. Many users are highlighting the stock's significant gains, with some pointing to recent price target increases by major financial institutions as a sign of confidence in the aerospace giant's recovery. The chatter reflects a renewed interest in the firm's strategic direction, particularly in its core markets.

Additionally, there’s notable buzz around Rolls-Royce's potential ventures, such as its small modular reactor (SMR) division, which has sparked curiosity among users about future growth prospects. Posts on X suggest that while some see this as an innovative move, others are debating the timeline for tangible financial impact. This mix of optimism and caution keeps the conversation dynamic and engaging.

Note: This discussion summary was generated from an AI condensation of post data.

Rolls-Royce Holdings Insider Trading Activity

Rolls-Royce Holdings insiders have traded $RR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $RR stock by insiders over the last 6 months:

• PHIL ZHENG (Chief Operating Officer) has made 0 purchases and 5 sales selling 400,000 shares for an estimated $1,327,573.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Rolls-Royce Holdings Hedge Fund Activity

We have seen 63 institutional investors add shares of Rolls-Royce Holdings stock to their portfolio, and 24 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. added 3,626,455 shares (+387.7%) to their portfolio in Q2 2025, for an estimated $7,071,587
• VANGUARD GROUP INC removed 1,469,700 shares (-45.7%) from their portfolio in Q2 2025, for an estimated $2,865,915
• BANK OF AMERICA CORP /DE/ added 1,211,256 shares (+3231.2%) to their portfolio in Q2 2025, for an estimated $2,361,949
• STATE STREET CORP added 1,164,978 shares (+490.7%) to their portfolio in Q2 2025, for an estimated $2,271,707
• GEODE CAPITAL MANAGEMENT, LLC added 824,253 shares (+128.9%) to their portfolio in Q2 2025, for an estimated $1,607,293
• NORTHERN TRUST CORP added 385,405 shares (+329.4%) to their portfolio in Q2 2025, for an estimated $751,539
• OMERS ADMINISTRATION CORP removed 355,300 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $692,835

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Rolls-Royce Holdings Analyst Ratings

Wall Street analysts have issued reports on $RR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 09/19/2025

To track analyst ratings and price targets for Rolls-Royce Holdings, check out Quiver Quantitative's $RR forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Adobe Inc. (ADBE) have been notably active, with much of the focus centered on a recent downgrade by a major financial institution. Many users have expressed concern over the slower-than-expected monetization of AI features, which some believe could hinder the company’s growth trajectory. The stock’s year-to-date decline has fueled debates about whether current prices reflect a buying opportunity or signal deeper challenges ahead.

Additionally, there’s a mix of perspectives on Adobe’s financial health, with some highlighting strong revenue growth and cash flow as reasons for optimism. Others, however, point to analyst skepticism about the pace of innovation and competitive pressures in the software space. The conversation remains dynamic, as participants weigh the long-term potential of Adobe against short-term headwinds.

Note: This discussion summary was generated from an AI condensation of post data.

Adobe Inc. Congressional Stock Trading

Members of Congress have traded $ADBE stock 17 times in the past 6 months. Of those trades, 8 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $ADBE stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 4 times. They made 4 purchases worth up to $60,000 on 09/11, 06/06, 05/05, 04/09 and 0 sales.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 08/05.
• REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $15,000 on 07/29.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/23 and 1 sale worth up to $15,000 on 07/10.
• SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 1 purchase worth up to $50,000 on 05/13 and 1 sale worth up to $50,000 on 04/08.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 05/08 and 2 sales worth up to $100,000 on 05/12, 04/07.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE ROBERT BRESNAHAN purchased up to $50,000 on 04/08.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Adobe Inc. Insider Trading Activity

Adobe Inc. insiders have traded $ADBE stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $ADBE stock by insiders over the last 6 months:

• JILLIAN FORUSZ (SVP & CAO) sold 462 shares for an estimated $175,827

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Adobe Inc. Hedge Fund Activity

We have seen 1,186 institutional investors add shares of Adobe Inc. stock to their portfolio, and 1,327 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GAMMA INVESTING LLC removed 2,982,862 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $1,154,009,650
• EDGEWOOD MANAGEMENT LLC removed 2,928,512 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $1,132,982,722
• ASSENAGON ASSET MANAGEMENT S.A. added 2,347,562 shares (+308.1%) to their portfolio in Q2 2025, for an estimated $908,224,786
• CAPITAL WORLD INVESTORS added 1,676,339 shares (+53.9%) to their portfolio in Q2 2025, for an estimated $648,542,032
• PRIMECAP MANAGEMENT CO/CA/ removed 1,264,055 shares (-23.3%) from their portfolio in Q2 2025, for an estimated $489,037,598
• OVERSEA-CHINESE BANKING CORP LTD removed 1,225,673 shares (-94.4%) from their portfolio in Q2 2025, for an estimated $474,188,370
• PACER ADVISORS, INC. added 1,011,457 shares (+1868.7%) to their portfolio in Q2 2025, for an estimated $391,312,484

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Adobe Inc. Government Contracts

We have seen $41,009 of award payments to $ADBE over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• SOPFTWARE: $31,290
• SOFTWARE: $9,718

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Adobe Inc. Analyst Ratings

Wall Street analysts have issued reports on $ADBE in the last several months. We have seen 11 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 09/12/2025
• Evercore ISI Group issued a "Outperform" rating on 09/12/2025
• RBC Capital issued a "Outperform" rating on 09/12/2025
• DA Davidson issued a "Buy" rating on 09/12/2025
• Piper Sandler issued a "Overweight" rating on 09/12/2025
• Oppenheimer issued a "Outperform" rating on 09/09/2025
• Mizuho issued a "Outperform" rating on 09/08/2025

To track analyst ratings and price targets for Adobe Inc., check out Quiver Quantitative's $ADBE forecast page.

Adobe Inc. Price Targets

Multiple analysts have issued price targets for $ADBE recently. We have seen 18 analysts offer price targets for $ADBE in the last 6 months, with a median target of $455.0.

Here are some recent targets:

• Keith Weiss from Morgan Stanley set a target price of $450.0 on 09/24/2025
• Saket Kalia from Barclays set a target price of $465.0 on 09/12/2025
• Brent Bracelin from Piper Sandler set a target price of $470.0 on 09/12/2025
• Keith Bachman from BMO Capital set a target price of $405.0 on 09/12/2025
• Karl Keirstead from UBS set a target price of $375.0 on 09/12/2025
• Kirk Materne from Evercore ISI Group set a target price of $450.0 on 09/12/2025
• Matthew Swanson from RBC Capital set a target price of $430.0 on 09/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Immuneering Corporation (IMRX) have been ignited by the company's announcement of a $175 million public offering and a concurrent $25 million private placement with Sanofi. Many users are debating the implications of this significant capital raise, with some expressing concern over the stock's immediate dip in price following the news, while others see it as a potential long-term positive due to the involvement of a major player like Sanofi. The volatility in the stock price has kept the conversation lively and speculative.

Additionally, the release of updated survival data from Immuneering’s Phase 2a trial for pancreatic cancer treatment has sparked further interest on the platform. Posts highlight the impressive 86% survival rate at nine months, with some users optimistic about the potential for a Phase 3 trial by year-end. This mix of financial and clinical developments continues to drive intense engagement among investors and industry watchers on X.

Note: This discussion summary was generated from an AI condensation of post data.

Immuneering Corporation Insider Trading Activity

Immuneering Corporation insiders have traded $IMRX stock on the open market 14 times in the past 6 months. Of those trades, 14 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $IMRX stock by insiders over the last 6 months:

• PETER FEINBERG has made 3 purchases buying 37,500 shares for an estimated $151,817 and 0 sales.
• THOMAS J. SCHALL has made 2 purchases buying 49,985 shares for an estimated $124,065 and 0 sales.
• BENJAMIN J. ZESKIND (PRESIDENT AND CEO) has made 3 purchases buying 31,000 shares for an estimated $85,023 and 0 sales.
• BRETT MATTHEW HALL (CHIEF SCIENTIFIC OFFICER) has made 2 purchases buying 13,422 shares for an estimated $34,616 and 0 sales.
• DIANA HAUSMAN has made 2 purchases buying 5,500 shares for an estimated $19,862 and 0 sales.
• HAROLD EUGENE BRAKEWOOD (Chief Business Officer) purchased 1,900 shares for an estimated $4,804
• LEAH R NEUFELD (CHIEF PEOPLE OFFICER) purchased 700 shares for an estimated $2,498

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Immuneering Corporation Hedge Fund Activity

We have seen 19 institutional investors add shares of Immuneering Corporation stock to their portfolio, and 13 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ removed 659,009 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,220,860
• MORGAN STANLEY removed 266,132 shares (-57.0%) from their portfolio in Q2 2025, for an estimated $896,864
• MARSHALL WACE, LLP removed 234,105 shares (-29.0%) from their portfolio in Q2 2025, for an estimated $788,933
• FMR LLC added 221,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $744,770
• BLACKROCK, INC. added 106,228 shares (+33.6%) to their portfolio in Q2 2025, for an estimated $357,988
• MANUFACTURERS LIFE INSURANCE COMPANY, THE removed 82,667 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $278,587
• TD ASSET MANAGEMENT INC removed 71,066 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $239,492

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Immuneering Corporation Analyst Ratings

Wall Street analysts have issued reports on $IMRX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 09/30/2025
• Chardan Capital issued a "Buy" rating on 09/26/2025
• Oppenheimer issued a "Outperform" rating on 09/25/2025
• Needham issued a "Buy" rating on 09/15/2025
• Mizuho issued a "Outperform" rating on 06/18/2025

To track analyst ratings and price targets for Immuneering Corporation, check out Quiver Quantitative's $IMRX forecast page.

Immuneering Corporation Price Targets

Multiple analysts have issued price targets for $IMRX recently. We have seen 5 analysts offer price targets for $IMRX in the last 6 months, with a median target of $11.0.

Here are some recent targets:

• Ami Fadia from HC Wainwright & Co. set a target price of $11.0 on 09/30/2025
• Geulah Livshits from Chardan Capital set a target price of $20.0 on 09/26/2025
• Jay Olson from Oppenheimer set a target price of $30.0 on 09/25/2025
• Ami Fadia from Needham set a target price of $11.0 on 09/15/2025
• Graig Suvannavejh from Mizuho set a target price of $10.0 on 06/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Apple Inc. (AAPL) have been buzzing with opinions following reports of strong iPhone 16 preorders and mixed analyst sentiments. Many users are highlighting the potential for growth driven by new AI features and upgraded intelligence in Apple’s ecosystem, sparking optimism about a possible re-rating of the stock. However, there are also notes of caution as some point to valuation concerns and weaker upgrade tailwinds flagged by analysts.

Additionally, posts on X reflect a divide between those who see sustained momentum with the latest iPhone release and others who are wary of market realism over growth expectations. Some discussions also touch on analyst downgrades and reiterations of hold ratings due to perceived slowing momentum. The conversation remains dynamic, with investors keenly watching for Apple’s next strategic moves amidst broader market uncertainties.

Note: This discussion summary was generated from an AI condensation of post data.

Apple Inc. Congressional Stock Trading

Members of Congress have traded $AAPL stock 40 times in the past 6 months. Of those trades, 25 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $AAPL stock by members of Congress over the last 6 months:

• SENATOR ADAM B. SCHIFF sold up to $50,000 on 09/22.
• REPRESENTATIVE CLEO FIELDS has traded it 16 times. They made 16 purchases worth up to $1,825,000 on 09/10, 09/03, 08/14, 08/01, 07/29, 06/30, 06/25, 06/09, 06/03 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/17, 06/09 and 1 sale worth up to $15,000 on 07/22.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 07/18.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
• REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
• REPRESENTATIVE VAL T. HOYLE purchased up to $15,000 on 06/06.
• REPRESENTATIVE TIM MOORE has traded it 2 times. They made 1 purchase worth up to $100,000 on 06/02 and 1 sale worth up to $250,000 on 06/02.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $250,000 on 04/07 and 2 sales worth up to $1,250,000 on 05/12, 05/08.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/05, 04/09, 04/03 and 0 sales.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $50,000 on 04/21.
• SENATOR TOMMY TUBERVILLE sold up to $50,000 on 04/15.
• SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 04/14.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE TERRI A. SEWELL purchased up to $15,000 on 04/10.
• REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 04/09.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Apple Inc. Insider Trading Activity

Apple Inc. insiders have traded $AAPL stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $AAPL stock by insiders over the last 6 months:

• TIMOTHY D COOK (Chief Executive Officer) has made 0 purchases and 4 sales selling 108,136 shares for an estimated $24,184,658.
• ARTHUR D LEVINSON sold 90,000 shares for an estimated $20,886,300
• KATHERINE L. ADAMS (SVP, GC and Secretary) has made 0 purchases and 4 sales selling 38,822 shares for an estimated $8,683,252.
• JEFFREY E WILLIAMS (COO) has made 0 purchases and 3 sales selling 35,493 shares for an estimated $7,950,690.
• DEIRDRE O'BRIEN (Senior Vice President) sold 34,821 shares for an estimated $7,772,047
• KEVAN PAREKH (Senior Vice President, CFO) sold 4,570 shares for an estimated $941,420
• CHRIS KONDO (Principal Accounting Officer) sold 4,486 shares for an estimated $933,955

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Apple Inc. Hedge Fund Activity

We have seen 2,271 institutional investors add shares of Apple Inc. stock to their portfolio, and 2,929 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 205,656,808 shares (+573627.2%) to their portfolio in Q2 2025, for an estimated $42,194,607,297
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 106,910,669 shares (+799.6%) to their portfolio in Q2 2025, for an estimated $21,934,861,958
• GAMMA INVESTING LLC removed 59,788,635 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $12,266,834,242
• PKS ADVISORY SERVICES, LLC added 57,898,088 shares (+98917.0%) to their portfolio in Q2 2025, for an estimated $11,878,950,714
• VALEO FINANCIAL ADVISORS, LLC added 25,821,539 shares (+3360.4%) to their portfolio in Q2 2025, for an estimated $5,297,805,156
• FMR LLC removed 21,341,586 shares (-6.5%) from their portfolio in Q2 2025, for an estimated $4,378,653,199
• BERKSHIRE HATHAWAY INC removed 20,000,000 shares (-6.7%) from their portfolio in Q2 2025, for an estimated $4,103,399,999

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Apple Inc. Government Contracts

We have seen $7,470 of award payments to $AAPL over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• CREDIT CARD PURCHASE POP DATES: 09/29/2025 TO 09/28/2026 FIRM FIXED PRICE: $7,470

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Apple Inc. Analyst Ratings

Wall Street analysts have issued reports on $AAPL in the last several months. We have seen 12 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Seaport Global issued a "Buy" rating on 10/01/2025
• Evercore ISI Group issued a "Outperform" rating on 09/26/2025
• Wedbush issued a "Outperform" rating on 09/22/2025
• Bernstein issued a "Outperform" rating on 09/16/2025
• Phillip Securities issued a "Reduce" rating on 09/11/2025
• Melius Research issued a "Buy" rating on 09/10/2025
• B of A Securities issued a "Buy" rating on 09/10/2025

To track analyst ratings and price targets for Apple Inc., check out Quiver Quantitative's $AAPL forecast page.

Apple Inc. Price Targets

Multiple analysts have issued price targets for $AAPL recently. We have seen 23 analysts offer price targets for $AAPL in the last 6 months, with a median target of $241.0.

Here are some recent targets:

• Jay Goldberg from Seaport Global set a target price of $310.0 on 10/01/2025
• Amit Daryanani from Evercore ISI Group set a target price of $290.0 on 09/26/2025
• Daniel Ives from Wedbush set a target price of $310.0 on 09/22/2025
• Ivan Feinseth from Tigress Financial set a target price of $305.0 on 09/17/2025
• Toni Sacconaghi from Bernstein set a target price of $290.0 on 09/16/2025
• Helena Wang from Phillip Securities set a target price of $200.0 on 09/11/2025
• Gil Luria from DA Davidson set a target price of $250.0 on 09/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about United Parcel Service (UPS) have been dominated by the company's strategic decision to reduce delivery volume with a major customer, widely believed to be Amazon, by more than half by 2026. This move has sparked intense debate, with some expressing concern that it could significantly impact revenue in an already challenging market. The stock's decline in recent months has only fueled speculation about the long-term implications of this pivot.

Additionally, posts on X have highlighted UPS's high dividend yield as a potential draw for investors, though others caution that declining sales volumes and competitive pressures from e-commerce giants could pose risks. The lack of a clear full-year outlook following the latest earnings report has also been a point of contention, with many questioning the company's direction amid global trade uncertainties. These conversations reflect a broader unease about whether UPS can adapt to a rapidly evolving logistics landscape.

Note: This discussion summary was generated from an AI condensation of post data.

United Parcel Service Congressional Stock Trading

Members of Congress have traded $UPS stock 24 times in the past 6 months. Of those trades, 9 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $UPS stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 4 times. They made 4 purchases worth up to $60,000 on 08/28, 08/04, 05/05, 04/04 and 0 sales.
• REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 08/18.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 08/05, 04/29.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 08/04, 06/17 and 1 sale worth up to $15,000 on 07/16.
• REPRESENTATIVE SCOTT FRANKLIN has traded it 4 times. They made 0 purchases and 4 sales worth up to $145,000 on 07/22, 06/16.
• REPRESENTATIVE KELLY MORRISON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 06/04.
• REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 05/28.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $100,000 on 04/07 and 2 sales worth up to $100,000 on 05/08, 04/17.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/15, 04/11.
• REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

United Parcel Service Insider Trading Activity

United Parcel Service insiders have traded $UPS stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $UPS stock by insiders over the last 6 months:

• CAROL B TOME (Chief Executive Officer) purchased 11,682 shares for an estimated $1,000,815
• WILLIAM R JOHNSON purchased 5,000 shares for an estimated $432,477
• CHRISTIANA SMITH SHI purchased 500 shares for an estimated $44,084

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

United Parcel Service Hedge Fund Activity

We have seen 986 institutional investors add shares of United Parcel Service stock to their portfolio, and 1,075 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP removed 10,760,184 shares (-94.4%) from their portfolio in Q2 2025, for an estimated $1,086,132,972
• VICTORY CAPITAL MANAGEMENT INC added 6,595,764 shares (+1039.5%) to their portfolio in Q2 2025, for an estimated $665,776,418
• JPMORGAN CHASE & CO removed 4,854,847 shares (-33.6%) from their portfolio in Q2 2025, for an estimated $490,048,256
• AMUNDI removed 4,830,715 shares (-64.5%) from their portfolio in Q2 2025, for an estimated $487,612,372
• BANK OF AMERICA CORP /DE/ removed 3,527,322 shares (-29.0%) from their portfolio in Q2 2025, for an estimated $356,047,882
• WELLS FARGO & COMPANY/MN removed 2,525,242 shares (-46.3%) from their portfolio in Q2 2025, for an estimated $254,897,927
• BLACKROCK, INC. added 2,470,981 shares (+5.2%) to their portfolio in Q2 2025, for an estimated $249,420,822

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

United Parcel Service Government Contracts

We have seen $106,216,818 of award payments to $UPS over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• SMALL PARCEL DELIVERY SERVICES FOR IRS LOCATIONS NATIONWIDE.: $12,972,527
• CONSOLIDATED TRANSPORTATION SHIPMENTS MADE BY DECENTRALIZED ORDERING OFFICERS.: $11,342,409
• CONSOLIDATED TRANSPORTATION SHIPMENTS MADE BY DECENTRALIZED ORDERING OFFICERS.: $10,569,271
• CONSOLIDATED TRANSPORTATION SHIPMENTS MADE BY DECENTRALIZED ORDERING OFFICERS.: $6,509,792
• TASK ORDER FOR DOMESTIC DELIVERY SERVICES PAID BY INVOICE: $4,464,000

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

United Parcel Service Analyst Ratings

Wall Street analysts have issued reports on $UPS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Underperform" rating on 09/11/2025
• Barclays issued a "Underweight" rating on 07/31/2025
• Citigroup issued a "Buy" rating on 07/31/2025
• Truist Securities issued a "Buy" rating on 07/30/2025
• Oppenheimer issued a "Outperform" rating on 07/30/2025
• Stifel issued a "Buy" rating on 07/30/2025
• UBS issued a "Buy" rating on 07/30/2025

To track analyst ratings and price targets for United Parcel Service, check out Quiver Quantitative's $UPS forecast page.

United Parcel Service Price Targets

Multiple analysts have issued price targets for $UPS recently. We have seen 15 analysts offer price targets for $UPS in the last 6 months, with a median target of $100.0.

Here are some recent targets:

• Ken Hoexter from B of A Securities set a target price of $81.0 on 09/26/2025
• Fadi Chamoun from BMO Capital set a target price of $96.0 on 09/19/2025
• Brandon Oglenski from Barclays set a target price of $80.0 on 07/31/2025
• Ariel Rosa from Citigroup set a target price of $114.0 on 07/31/2025
• J. Bruce Chan from Stifel set a target price of $120.0 on 07/30/2025
• Thomas Wadewitz from UBS set a target price of $118.0 on 07/30/2025
• Ravi Shanker from Morgan Stanley set a target price of $75.0 on 07/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Target Corporation (TGT) have centered around rumors of a potential private equity takeover, sparked by a Fox Business report. Many users are buzzing about the implications of a new CEO transition and the company's better-than-expected Q2 results, though the stock remains near multi-year lows. The speculation has driven noticeable interest and volatility in the stock's price movement.

Additionally, there’s ongoing chatter about Target's valuation and long-term potential, with some on X pointing to its low price-to-earnings ratio and high dividend yield as attractive metrics for investors. However, concerns linger over recent earnings misses and declining holiday sales projections, casting a shadow over the optimism. The conversation reflects a complex mix of hope and caution among retail investors.

Note: This discussion summary was generated from an AI condensation of post data.

Target Corporation Congressional Stock Trading

Members of Congress have traded $TGT stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $TGT stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 08/18.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 04/11.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Target Corporation Insider Trading Activity

Target Corporation insiders have traded $TGT stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $TGT stock by insiders over the last 6 months:

• BRIAN C CORNELL (Executive Officer) sold 45,000 shares for an estimated $4,327,974
• MATTHEW A LIEGEL (Chief Accounting Officer) sold 2,044 shares for an estimated $206,244

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Target Corporation Hedge Fund Activity

We have seen 737 institutional investors add shares of Target Corporation stock to their portfolio, and 974 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 6,607,982 shares (+14.7%) to their portfolio in Q2 2025, for an estimated $651,877,424
• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 6,039,933 shares (+inf%) to their portfolio in Q2 2025, for an estimated $595,839,390
• WELLS FARGO & COMPANY/MN removed 4,176,864 shares (-48.6%) from their portfolio in Q2 2025, for an estimated $412,047,633
• CLEARBRIDGE INVESTMENTS, LLC removed 2,360,450 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $232,858,392
• MORGAN STANLEY added 2,129,119 shares (+29.1%) to their portfolio in Q2 2025, for an estimated $210,037,589
• STATE STREET CORP added 1,529,026 shares (+4.3%) to their portfolio in Q2 2025, for an estimated $150,838,414
• AMUNDI removed 1,376,965 shares (-49.9%) from their portfolio in Q2 2025, for an estimated $135,837,597

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Target Corporation Analyst Ratings

Wall Street analysts have issued reports on $TGT in the last several months. We have seen 7 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

• Wolfe Research issued a "Underperform" rating on 09/18/2025
• Guggenheim issued a "Buy" rating on 08/21/2025
• RBC Capital issued a "Outperform" rating on 08/21/2025
• UBS issued a "Buy" rating on 08/21/2025
• Jefferies issued a "Buy" rating on 08/20/2025
• B of A Securities issued a "Underperform" rating on 08/15/2025
• Morgan Stanley issued a "Overweight" rating on 05/22/2025

To track analyst ratings and price targets for Target Corporation, check out Quiver Quantitative's $TGT forecast page.

Target Corporation Price Targets

Multiple analysts have issued price targets for $TGT recently. We have seen 21 analysts offer price targets for $TGT in the last 6 months, with a median target of $107.0.

Here are some recent targets:

• Greg Melich from Evercore ISI Group set a target price of $105.0 on 09/23/2025
• Spencer Hanus from Wolfe Research set a target price of $80.0 on 09/18/2025
• Paul Lejuez from Citigroup set a target price of $100.0 on 08/22/2025
• John Heinbockel from Guggenheim set a target price of $115.0 on 08/21/2025
• Steven Shemesh from RBC Capital set a target price of $107.0 on 08/21/2025
• Michael Lasser from UBS set a target price of $130.0 on 08/21/2025
• Corey Tarlowe from Jefferies set a target price of $115.0 on 08/20/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about CoreWeave (CRWV) have been ignited by the announcement of a massive $14.2 billion partnership with Meta Platforms for AI cloud services. Many users are buzzing about the stock’s sharp rise, with some noting a breakout above key resistance levels and others highlighting the potential for further gains as the AI sector continues to heat up. The news of additional contracts worth $42 billion with major players like Nvidia and OpenAI has only added fuel to the conversation.

While enthusiasm dominates, there are pockets of caution among the chatter on X, with some pointing to the company’s financial challenges, including significant liabilities and recent debt issuance. Despite these concerns, the momentum behind CoreWeave appears strong, as posts frequently mention analyst upgrades and institutional interest as reasons for optimism. The dynamic mix of reactions keeps the dialogue around CRWV lively and engaging.

Note: This discussion summary was generated from an AI condensation of post data.

CoreWeave Congressional Stock Trading

Members of Congress have traded $CRWV stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CRWV stock by members of Congress over the last 6 months:

• REPRESENTATIVE VAL T. HOYLE purchased up to $15,000 on 06/06.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CoreWeave Insider Trading Activity

CoreWeave insiders have traded $CRWV stock on the open market 622 times in the past 6 months. Of those trades, 0 have been purchases and 622 have been sales.

Here’s a breakdown of recent trading of $CRWV stock by insiders over the last 6 months:

• FINANCIAL LLC MAGNETAR has made 0 purchases and 369 sales selling 12,420,804 shares for an estimated $1,481,104,570.
• JACK D COGEN has made 0 purchases and 14 sales selling 5,112,004 shares for an estimated $477,148,645.
• BRANNIN MCBEE (Chief Development Officer) has made 0 purchases and 94 sales selling 3,750,000 shares for an estimated $391,456,337.
• BRIAN M VENTURO (Chief Strategy Officer) has made 0 purchases and 46 sales selling 925,632 shares for an estimated $91,055,107.
• KRISTEN J MCVEETY (GC and Secretary) has made 0 purchases and 23 sales selling 409,088 shares for an estimated $41,942,801.
• MICHAEL N INTRATOR (CEO and President) has made 0 purchases and 54 sales selling 247,365 shares for an estimated $28,374,030.
• NITIN AGRAWAL (Chief Financial Officer) has made 0 purchases and 16 sales selling 111,174 shares for an estimated $12,694,470.
• CHEN GOLDBERG (SVP of Engineering) has made 0 purchases and 6 sales selling 56,294 shares for an estimated $5,244,848.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CoreWeave Analyst Ratings

Wall Street analysts have issued reports on $CRWV in the last several months. We have seen 14 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Evercore ISI Group issued a "Outperform" rating on 09/30/2025
• Wells Fargo issued a "Overweight" rating on 09/23/2025
• Loop Capital issued a "Buy" rating on 09/19/2025
• Raymond James issued a "Outperform" rating on 09/16/2025
• JMP Securities issued a "Market Outperform" rating on 09/16/2025
• Cantor Fitzgerald issued a "Overweight" rating on 09/16/2025
• HC Wainwright & Co. issued a "Buy" rating on 08/21/2025

To track analyst ratings and price targets for CoreWeave, check out Quiver Quantitative's $CRWV forecast page.

CoreWeave Price Targets

Multiple analysts have issued price targets for $CRWV recently. We have seen 25 analysts offer price targets for $CRWV in the last 6 months, with a median target of $140.0.

Here are some recent targets:

• Amit Daryanani from Evercore ISI Group set a target price of $175.0 on 09/30/2025
• Paul Golding from Macquarie set a target price of $140.0 on 09/29/2025
• Michael Turrin from Wells Fargo set a target price of $170.0 on 09/23/2025
• Ben Reitzes from Melius Research set a target price of $165.0 on 09/23/2025
• Ananda Baruah from Loop Capital set a target price of $165.0 on 09/19/2025
• Josh Beck from Raymond James set a target price of $130.0 on 09/16/2025
• Greg P. Miller from JMP Securities set a target price of $180.0 on 09/16/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Rezolve AI (RZLV) have been ignited by the company's latest financial updates, particularly their raised guidance for 2025 and 2026 annual recurring revenue (ARR) targets. Many users are highlighting the impressive 426% year-over-year revenue growth for the first half of 2025, seeing it as a strong indicator of the company's potential in the AI-driven commerce space. The buzz is amplified by strategic partnerships with major tech giants, which some argue positions Rezolve AI as a key player in the industry.

However, not all chatter is overwhelmingly positive, as some voices on X express caution over the widened net loss reported for the same period, questioning the sustainability of the growth trajectory. Concerns about potential volatility and the impact of private placements on liquidity have also surfaced in the conversations. Despite these reservations, the predominant focus remains on the ambitious forecasts and technological advancements, keeping the dialogue dynamic and engaging.

Note: This discussion summary was generated from an AI condensation of post data.

Rezolve AI Analyst Ratings

Wall Street analysts have issued reports on $RZLV in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 09/15/2025
• Roth Capital issued a "Buy" rating on 09/15/2025
• Alliance Global Partners issued a "Buy" rating on 08/01/2025

To track analyst ratings and price targets for Rezolve AI, check out Quiver Quantitative's $RZLV forecast page.

Rezolve AI Price Targets

Multiple analysts have issued price targets for $RZLV recently. We have seen 3 analysts offer price targets for $RZLV in the last 6 months, with a median target of $9.0.

Here are some recent targets:

• Scott Buck from HC Wainwright & Co. set a target price of $9.0 on 09/15/2025
• Rohit Kulkarni from Roth Capital set a target price of $9.0 on 09/15/2025
• Brian Kinstlinger from Alliance Global Partners set a target price of $8.5 on 08/01/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about GameStop (GME) have been fueled by the company's latest earnings report and strategic announcements, including a stock split and warrant program. Many users are expressing intrigue over the reported surge in the collectibles business, particularly with new Pokémon card set launches, which has sparked debates about the long-term impact on revenue. The stock's recent price movements, bolstered by positive market sentiment, have kept the conversation lively and dynamic.

Additionally, there’s a strong focus on GameStop's future, with some on X speculating about potential growth tied to upcoming Q4 expectations and broader market trends like a possible Santa rally. Others have highlighted the company's substantial cash reserves as a key strength in navigating volatility. The mix of optimism and cautious analysis continues to drive engagement around this iconic meme stock.

Note: This discussion summary was generated from an AI condensation of post data.

GameStop Congressional Stock Trading

Members of Congress have traded $GME stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $GME stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GameStop Insider Trading Activity

GameStop insiders have traded $GME stock on the open market 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $GME stock by insiders over the last 6 months:

• RYAN COHEN (President, CEO and Chairman) purchased 500,000 shares for an estimated $10,775,000
• MARK HAYMOND ROBINSON (General Counsel and Secretary) has made 0 purchases and 4 sales selling 17,041 shares for an estimated $404,015.
• ALAIN ATTAL purchased 10,000 shares for an estimated $257,500
• JAMES GRUBE purchased 5,575 shares for an estimated $132,183
• LAWRENCE CHENG purchased 5,000 shares for an estimated $107,700
• DANIEL WILLIAM MOORE (PFO and PAO) has made 0 purchases and 3 sales selling 3,159 shares for an estimated $72,319.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GameStop Hedge Fund Activity

We have seen 179 institutional investors add shares of GameStop stock to their portfolio, and 134 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MARSHALL WACE, LLP added 5,170,741 shares (+347.7%) to their portfolio in Q2 2025, for an estimated $126,114,372
• INVESCO LTD. added 3,200,321 shares (+486.6%) to their portfolio in Q2 2025, for an estimated $78,055,829
• GOLDMAN SACHS GROUP INC added 3,156,461 shares (+1204.1%) to their portfolio in Q2 2025, for an estimated $76,986,083
• NORGES BANK added 3,080,586 shares (+4799.3%) to their portfolio in Q2 2025, for an estimated $75,135,492
• CLEAR STREET LLC added 2,354,779 shares (+inf%) to their portfolio in Q2 2025, for an estimated $57,433,059
• CITADEL ADVISORS LLC added 2,173,746 shares (+78.4%) to their portfolio in Q2 2025, for an estimated $53,017,664
• BANK OF MONTREAL /CAN/ added 2,136,926 shares (+1673.5%) to their portfolio in Q2 2025, for an estimated $52,119,625

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GameStop Analyst Ratings

Wall Street analysts have issued reports on $GME in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Wedbush issued a "Underperform" rating on 06/11/2025

To track analyst ratings and price targets for GameStop, check out Quiver Quantitative's $GME forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent chatter on X about Tesla, Inc. (TSLA) has centered around the company’s upcoming catalysts for the remainder of 2025, particularly the anticipated release of a low-cost mass market vehicle and the progress of Full Self-Driving (FSD) technology. Many users are buzzing with excitement over potential Q3 delivery numbers and earnings guidance, seeing these as pivotal moments for the stock’s trajectory. The energy business’s growth also appears to be a hot topic, with some pointing to it as a significant driver of future value.

However, not all discussions are uniformly positive, as concerns linger over regulatory hurdles and competitive pressures in the EV and autonomous driving spaces. Some voices on X highlight potential risks, including scrutiny over FSD software safety at railroad crossings, which has sparked calls for investigation. This blend of optimism and caution keeps Tesla at the forefront of heated debates among investors and enthusiasts on the platform.

Note: This discussion summary was generated from an AI condensation of post data.

Tesla, Inc. Congressional Stock Trading

Members of Congress have traded $TSLA stock 19 times in the past 6 months. Of those trades, 15 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $TSLA stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 08/05.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/17, 06/09 and 1 sale worth up to $15,000 on 07/10.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 5 times. They made 5 purchases worth up to $75,000 on 06/05, 05/23, 05/16, 05/12, 04/08 and 0 sales.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 5 times. They made 4 purchases worth up to $60,000 on 05/29, 05/27, 05/16, 05/15 and 1 sale worth up to $15,000 on 06/05.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/14, 05/05, 04/08 and 0 sales.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $250,000 on 05/12.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Tesla, Inc. Insider Trading Activity

Tesla, Inc. insiders have traded $TSLA stock on the open market 107 times in the past 6 months. Of those trades, 26 have been purchases and 81 have been sales.

Here’s a breakdown of recent trading of $TSLA stock by insiders over the last 6 months:

• ELON MUSK (CEO) has made 25 purchases buying 2,568,732 shares for an estimated $999,959,042 and 0 sales.
• IRA MATTHEW EHRENPREIS has made 0 purchases and 16 sales selling 477,572 shares for an estimated $170,636,358.
• JAMES R MURDOCH has made 0 purchases and 2 sales selling 180,000 shares for an estimated $67,395,120.
• ROBYN M DENHOLM has made 0 purchases and 15 sales selling 224,785 shares for an estimated $62,906,341.
• KIMBAL MUSK has made 0 purchases and 15 sales selling 91,588 shares for an estimated $32,732,229.
• XIAOTONG ZHU (SVP, APAC and) has made 0 purchases and 2 sales selling 35,000 shares for an estimated $12,132,205.
• VAIBHAV TANEJA (Chief Financial Officer) has made 0 purchases and 31 sales selling 33,169 shares for an estimated $10,206,281.
• JOSEPH GEBBIA purchased 4,000 shares for an estimated $1,025,232

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Tesla, Inc. Hedge Fund Activity

We have seen 2,120 institutional investors add shares of Tesla, Inc. stock to their portfolio, and 1,344 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GAMMA INVESTING LLC removed 9,764,260 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $3,101,714,831
• JPMORGAN CHASE & CO added 6,600,062 shares (+16.7%) to their portfolio in Q2 2025, for an estimated $2,096,575,694
• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 6,435,598 shares (+581880.5%) to their portfolio in Q2 2025, for an estimated $2,044,332,060
• ASSENAGON ASSET MANAGEMENT S.A. removed 4,981,129 shares (-58.8%) from their portfolio in Q2 2025, for an estimated $1,582,305,438
• VANGUARD GROUP INC added 4,502,976 shares (+1.8%) to their portfolio in Q2 2025, for an estimated $1,430,415,356
• GOLDMAN SACHS GROUP INC added 3,956,571 shares (+14.9%) to their portfolio in Q2 2025, for an estimated $1,256,844,343
• VALEO FINANCIAL ADVISORS, LLC added 3,774,780 shares (+6173.6%) to their portfolio in Q2 2025, for an estimated $1,199,096,614

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Tesla, Inc. Government Contracts

We have seen $17,357 of award payments to $TSLA over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• AUTOMOTIVE MECHANICAL REPAIRS: $17,357

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Tesla, Inc. Analyst Ratings

Wall Street analysts have issued reports on $TSLA in the last several months. We have seen 12 firms issue buy ratings on the stock, and 5 firms issue sell ratings.

Here are some recent analyst ratings:

• Canaccord Genuity issued a "Buy" rating on 09/30/2025
• Deutsche Bank issued a "Buy" rating on 09/26/2025
• Wedbush issued a "Outperform" rating on 09/26/2025
• Piper Sandler issued a "Overweight" rating on 09/22/2025
• Baird issued a "Outperform" rating on 09/19/2025
• RBC Capital issued a "Outperform" rating on 07/29/2025
• GLJ Research issued a "Sell" rating on 07/24/2025

To track analyst ratings and price targets for Tesla, Inc., check out Quiver Quantitative's $TSLA forecast page.

Tesla, Inc. Price Targets

Multiple analysts have issued price targets for $TSLA recently. We have seen 22 analysts offer price targets for $TSLA in the last 6 months, with a median target of $395.0.

Here are some recent targets:

• George Gianarikas from Canaccord Genuity set a target price of $490.0 on 09/30/2025
• Daniel Ives from Wedbush set a target price of $600.0 on 09/26/2025
• Edison Yu from Deutsche Bank set a target price of $435.0 on 09/26/2025
• Vijay Rakesh from Mizuho set a target price of $450.0 on 09/23/2025
• Alex Potter from Piper Sandler set a target price of $500.0 on 09/22/2025
• Ben Kallo from Baird set a target price of $548.0 on 09/19/2025
• Mark Delaney from Goldman Sachs set a target price of $395.0 on 09/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Transocean Ltd. (RIG) have been dominated by the company’s announcement of a public offering of 125 million shares at a discounted price of $3.05, significantly below the prior closing price. Many users expressed frustration over the dilution of existing shareholders, with some viewing the move as a desperate attempt to manage the company’s debt burden. The sharp decline in stock price following the announcement—down over 12% in after-hours trading—has fueled heated debates about the long-term viability of the offshore driller.

Despite the negative reactions, a few voices on X remain cautiously optimistic, pointing to technical indicators like a potential golden cross on the charts and the possibility of a new contracting cycle with higher day rates. Some have also noted a recent $12.2 million insider purchase as a signal of confidence from within. Still, the overarching tone reflects concern over persistent financial challenges and market pressures facing Transocean.

Note: This discussion summary was generated from an AI condensation of post data.

Transocean Ltd. Insider Trading Activity

Transocean Ltd. insiders have traded $RIG stock on the open market 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $RIG stock by insiders over the last 6 months:

• PERESTROIKA purchased 4,000,000 shares for an estimated $12,200,000
• FREDERIK WILHELM MOHN purchased 4,000,000 shares for an estimated $12,200,000
• (CYPRUS) LTD PERESTROIKA purchased 4,000,000 shares for an estimated $12,200,000
• RODERICK JAMES MACKENZIE (EVP, Chief Commercial Officer) has made 0 purchases and 3 sales selling 84,000 shares for an estimated $240,619.
• VANESSA C L CHANG purchased 10,000 shares for an estimated $21,400

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Transocean Ltd. Hedge Fund Activity

We have seen 212 institutional investors add shares of Transocean Ltd. stock to their portfolio, and 154 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRIMECAP MANAGEMENT CO/CA/ removed 40,723,249 shares (-75.6%) from their portfolio in Q2 2025, for an estimated $105,473,214
• ELLIOTT INVESTMENT MANAGEMENT L.P. removed 11,870,319 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $30,744,126
• CITADEL ADVISORS LLC added 7,923,043 shares (+242.2%) to their portfolio in Q2 2025, for an estimated $20,520,681
• MORGAN STANLEY added 6,480,573 shares (+54.3%) to their portfolio in Q2 2025, for an estimated $16,784,684
• TWO SIGMA ADVISERS, LP added 6,275,600 shares (+64.2%) to their portfolio in Q2 2025, for an estimated $16,253,804
• TWO SIGMA INVESTMENTS, LP added 4,901,384 shares (+35.9%) to their portfolio in Q2 2025, for an estimated $12,694,584
• JANE STREET GROUP, LLC added 4,704,440 shares (+1020.7%) to their portfolio in Q2 2025, for an estimated $12,184,499

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Transocean Ltd. Analyst Ratings

Wall Street analysts have issued reports on $RIG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 08/13/2025
• Susquehanna issued a "Positive" rating on 04/14/2025

To track analyst ratings and price targets for Transocean Ltd., check out Quiver Quantitative's $RIG forecast page.

Transocean Ltd. Price Targets

Multiple analysts have issued price targets for $RIG recently. We have seen 4 analysts offer price targets for $RIG in the last 6 months, with a median target of $3.75.

Here are some recent targets:

• Eddie Kim from Barclays set a target price of $4.0 on 08/13/2025
• Daniel Kutz from Morgan Stanley set a target price of $3.5 on 05/16/2025
• Charles Minervino from Susquehanna set a target price of $4.0 on 04/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent chatter on X about Alphabet Inc. (GOOGL) has been fueled by the company's advancements in AI and cloud services, with a particular focus on reported partnerships and product integrations. Many users are intrigued by talks of potential collaborations, such as Meta possibly leveraging Google's Gemini AI for advertising, which has sparked lively debates about future growth prospects. The stock's recent price movements have also drawn attention as a point of discussion among tech investors.

Additionally, posts on X highlight Alphabet's ongoing strategic moves, including significant capital expenditure increases for 2025, signaling confidence in long-term innovation. Some discussions reflect optimism about AI-driven ad and cloud growth, with analysts reportedly setting ambitious price targets. However, there are also notes of caution regarding regulatory challenges and competitive pressures in the AI space.

Note: This discussion summary was generated from an AI condensation of post data.

Alphabet Inc. Congressional Stock Trading

Members of Congress have traded $GOOGL stock 21 times in the past 6 months. Of those trades, 9 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 09/03.
• SENATOR SHELLEY MOORE CAPITO has traded it 3 times. They made 3 purchases worth up to $45,000 on 07/29, 05/08, 04/29 and 0 sales.
• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
• REPRESENTATIVE VAL T. HOYLE has traded it 4 times. They made 2 purchases worth up to $30,000 on 07/14, 07/02 and 2 sales worth up to $30,000 on 04/15, 04/02.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/24.
• REPRESENTATIVE JOHN W. ROSE sold up to $5,000,000 on 06/03.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 05/20.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $250,000 on 05/12.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• REPRESENTATIVE JONATHAN L. JACKSON sold up to $50,000 on 04/21.
• SENATOR TOMMY TUBERVILLE sold up to $50,000 on 04/15.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
• REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Alphabet Inc. Insider Trading Activity

Alphabet Inc. insiders have traded $GOOGL stock on the open market 110 times in the past 6 months. Of those trades, 0 have been purchases and 110 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by insiders over the last 6 months:

• SUNDAR PICHAI (Chief Executive Officer) has made 0 purchases and 63 sales selling 390,000 shares for an estimated $72,317,606.
• KAVITARK RAM SHRIRAM has made 0 purchases and 4 sales selling 59,566 shares for an estimated $11,565,220.
• JOHN KENT WALKER (President, Global Affairs, CLO) sold 23,820 shares for an estimated $4,637,754
• JOHN L. HENNESSY has made 0 purchases and 35 sales selling 4,000 shares for an estimated $784,712.
• AMIE THUENER O'TOOLE (VP, Chief Accounting Officer) sold 2,778 shares for an estimated $680,610
• FRANCES ARNOLD has made 0 purchases and 6 sales selling 649 shares for an estimated $124,813.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Alphabet Inc. Hedge Fund Activity

We have seen 2,440 institutional investors add shares of Alphabet Inc. stock to their portfolio, and 2,097 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GAMMA INVESTING LLC removed 15,944,572 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $2,809,911,923
• PRICE T ROWE ASSOCIATES INC /MD/ removed 14,910,314 shares (-16.7%) from their portfolio in Q2 2025, for an estimated $2,627,644,636
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 11,522,921 shares (+26.3%) to their portfolio in Q2 2025, for an estimated $2,030,684,367
• FRANKLIN RESOURCES INC added 10,843,853 shares (+51.7%) to their portfolio in Q2 2025, for an estimated $1,911,012,214
• CAPITAL RESEARCH GLOBAL INVESTORS removed 10,062,090 shares (-18.7%) from their portfolio in Q2 2025, for an estimated $1,773,242,120
• WELLINGTON MANAGEMENT GROUP LLP added 10,042,091 shares (+17.9%) to their portfolio in Q2 2025, for an estimated $1,769,717,696
• BLACKROCK, INC. removed 9,367,765 shares (-2.1%) from their portfolio in Q2 2025, for an estimated $1,650,881,225

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Alphabet Inc. Government Contracts

We have seen $3,948,863 of award payments to $GOOGL over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• STRATUS POOL 1 CLOUD SERVICE BOA TO FOR GOOGLE CLOUD SERVICE PROVIDER CORE SERVICES: $3,948,863

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Alphabet Inc. Analyst Ratings

Wall Street analysts have issued reports on $GOOGL in the last several months. We have seen 23 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 09/30/2025
• MoffettNathanson issued a "Buy" rating on 09/25/2025
• Truist Securities issued a "Buy" rating on 09/22/2025
• Piper Sandler issued a "Overweight" rating on 09/18/2025
• Citigroup issued a "Buy" rating on 09/15/2025
• Evercore ISI Group issued a "Outperform" rating on 09/08/2025
• Tigress Financial issued a "Strong Buy" rating on 09/05/2025

To track analyst ratings and price targets for Alphabet Inc., check out Quiver Quantitative's $GOOGL forecast page.

Alphabet Inc. Price Targets

Multiple analysts have issued price targets for $GOOGL recently. We have seen 34 analysts offer price targets for $GOOGL in the last 6 months, with a median target of $228.5.

Here are some recent targets:

• Lloyd Walmsley from Mizuho set a target price of $295.0 on 09/30/2025
• Michael Nathanson from MoffettNathanson set a target price of $295.0 on 09/25/2025
• Deepak Mathivanan from Cantor Fitzgerald set a target price of $201.0 on 09/24/2025
• Youssef Squali from Truist Securities set a target price of $285.0 on 09/22/2025
• Colin Sebastian from Baird set a target price of $275.0 on 09/22/2025
• Andrew Boone from JMP Securities set a target price of $290.0 on 09/19/2025
• Thomas Champion from Piper Sandler set a target price of $285.0 on 09/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Lithium Americas Corp (LAC) have been buzzing with excitement following news of the U.S. government's involvement in the company. Reports of a potential 5-10% equity stake by the Department of Energy, alongside a $435 million loan approval for the Thacker Pass project, have driven significant attention. Many users are highlighting the strategic importance of domestic lithium production for electric vehicle supply chains.

The stock saw dramatic premarket surges, with some posts noting jumps of up to 95% in response to these developments. Conversations also touch on the long-term potential of lithium demand, though concerns about price volatility linger in the discourse. This unfolding story continues to captivate investors tracking the energy transition narrative.

Note: This discussion summary was generated from an AI condensation of post data.

Lithium Americas Corp Insider Trading Activity

Lithium Americas Corp insiders have traded $LAC stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $LAC stock by insiders over the last 6 months:

• MICHAEL JOHN BROWN has made 3 purchases buying 2,100 shares for an estimated $5,831 and 0 sales.
• EDWARD GRANDY (Sr VP, GC & Secretary) sold 23 shares for an estimated $61

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Lithium Americas Corp Hedge Fund Activity

We have seen 75 institutional investors add shares of Lithium Americas Corp stock to their portfolio, and 86 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GK WEALTH MANAGEMENT LLC removed 1,198,961 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,213,215
• TOWNSQUARE CAPITAL LLC removed 1,045,384 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,801,629
• UBS GROUP AG added 856,215 shares (+47.8%) to their portfolio in Q2 2025, for an estimated $2,294,656
• DECADE RENEWABLE PARTNERS LP removed 680,100 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,822,668
• CITADEL ADVISORS LLC added 567,310 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,520,390
• RENAISSANCE TECHNOLOGIES LLC added 491,800 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,318,024
• LEGAL & GENERAL GROUP PLC removed 476,731 shares (-33.0%) from their portfolio in Q2 2025, for an estimated $1,277,639

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Lithium Americas Corp Analyst Ratings

Wall Street analysts have issued reports on $LAC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 09/24/2025
• Canaccord Genuity issued a "Buy" rating on 08/15/2025

To track analyst ratings and price targets for Lithium Americas Corp, check out Quiver Quantitative's $LAC forecast page.

Lithium Americas Corp Price Targets

Multiple analysts have issued price targets for $LAC recently. We have seen 4 analysts offer price targets for $LAC in the last 6 months, with a median target of $6.75.

Here are some recent targets:

• Daniel Ives from Wedbush set a target price of $8.0 on 10/01/2025
• David Deckelbaum from TD Cowen set a target price of $5.0 on 09/25/2025
• Laurence Alexander from Jefferies set a target price of $7.0 on 09/24/2025
• Katie Lachapelle from Canaccord Genuity set a target price of $6.5 on 08/15/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about SoFi Technologies (SOFI) have been lively, with much of the focus on the company’s upcoming Q3 2025 earnings call scheduled for October 28. Many users are expressing anticipation for the financial results, pointing to the fintech’s strong momentum in revenue growth and innovative product expansions as key areas to watch. The chatter reflects a keen interest in whether SoFi can sustain its growth trajectory amidst a competitive market.

While optimism dominates, there are also notes of caution circulating on the platform regarding the stock’s recent pullback after hitting new highs in September. Some discussions highlight concerns over short-term technical indicators and broader market pressures, as the stock has seen a decline over the past week. Despite this, the buzz around SoFi’s strategic moves, such as cross-border initiatives, continues to fuel engagement among investors on X.

Note: This discussion summary was generated from an AI condensation of post data.

SoFi Technologies Insider Trading Activity

SoFi Technologies insiders have traded $SOFI stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $SOFI stock by insiders over the last 6 months:

• JEREMY RISHEL (Chief Technology Officer) has made 0 purchases and 2 sales selling 165,580 shares for an estimated $3,754,628.
• MAGDALENA YESIL has made 0 purchases and 2 sales selling 174,280 shares for an estimated $2,469,800.
• KELLI KEOUGH (EVP, GBUL, SIPS) has made 0 purchases and 6 sales selling 63,849 shares for an estimated $1,167,555.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SoFi Technologies Hedge Fund Activity

We have seen 409 institutional investors add shares of SoFi Technologies stock to their portfolio, and 284 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VOLORIDGE INVESTMENT MANAGEMENT, LLC added 7,895,334 shares (+91.9%) to their portfolio in Q2 2025, for an estimated $143,774,032
• BANK OF AMERICA CORP /DE/ added 7,513,921 shares (+65.3%) to their portfolio in Q2 2025, for an estimated $136,828,501
• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 6,973,635 shares (-71.1%) from their portfolio in Q2 2025, for an estimated $126,989,893
• JANE STREET GROUP, LLC added 6,491,776 shares (+133.6%) to their portfolio in Q2 2025, for an estimated $118,215,240
• QUADRATURE CAPITAL LTD added 6,328,992 shares (+inf%) to their portfolio in Q2 2025, for an estimated $115,250,944
• QUBE RESEARCH & TECHNOLOGIES LTD removed 6,288,743 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $114,518,010
• UBS GROUP AG added 5,923,047 shares (+41.0%) to their portfolio in Q2 2025, for an estimated $107,858,685

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SoFi Technologies Analyst Ratings

Wall Street analysts have issued reports on $SOFI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 09/18/2025
• Needham issued a "Buy" rating on 09/10/2025
• Citigroup issued a "Buy" rating on 08/20/2025
• Keefe, Bruyette & Woods issued a "Underperform" rating on 08/05/2025
• Morgan Stanley issued a "Underweight" rating on 07/30/2025
• JMP Securities issued a "Market Outperform" rating on 04/25/2025

To track analyst ratings and price targets for SoFi Technologies, check out Quiver Quantitative's $SOFI forecast page.

SoFi Technologies Price Targets

Multiple analysts have issued price targets for $SOFI recently. We have seen 12 analysts offer price targets for $SOFI in the last 6 months, with a median target of $20.5.

Here are some recent targets:

• Jeffrey Adelson from Morgan Stanley set a target price of $18.0 on 09/29/2025
• Dan Dolev from Mizuho set a target price of $31.0 on 09/18/2025
• Kyle Peterson from Needham set a target price of $29.0 on 09/10/2025
• Reginald Smith from JP Morgan set a target price of $24.0 on 08/20/2025
• Ashwin Shirvaikar from Citigroup set a target price of $28.0 on 08/20/2025
• Timothy Switzer from Keefe, Bruyette & Woods set a target price of $14.0 on 08/05/2025
• Terry Ma from Barclays set a target price of $21.0 on 07/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Bitcoin Depot (BTM) have centered around the company's strong financial performance and its expanding network of cryptocurrency ATMs. Many users have highlighted the firm's latest quarterly revenue of $160 million, an 18% year-over-year increase, as a sign of robust growth in the crypto accessibility space. There’s a palpable excitement about the potential cash flow from their over 9,000 kiosks across North America and Australia.

Additionally, some conversations on X have focused on the stock’s price movements, with a few noting its recent surge and speculating on whether momentum can push it past key resistance levels. Others have pointed out the high insider ownership and leadership moves as factors that could drive long-term confidence. The chatter reflects a keen interest in how Bitcoin Depot navigates the volatile crypto market landscape.

Note: This discussion summary was generated from an AI condensation of post data.

Bitcoin Depot Insider Trading Activity

Bitcoin Depot insiders have traded $BTM stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $BTM stock by insiders over the last 6 months:

• BRANDON TAYLOR MINTZ (Chief Executive Officer) has made 0 purchases and 7 sales selling 556,903 shares for an estimated $2,046,420.
• CHRISTOPHER SCOTT BUCHANAN (COO and President) has made 0 purchases and 3 sales selling 49,476 shares for an estimated $144,552.
• MARK JAMES SMALLEY (Chief Compliance Officer) sold 3,188 shares for an estimated $12,688

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Bitcoin Depot Hedge Fund Activity

We have seen 46 institutional investors add shares of Bitcoin Depot stock to their portfolio, and 11 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• METEORA CAPITAL, LLC removed 2,071,016 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $10,500,051
• MARSHALL WACE, LLP added 808,127 shares (+inf%) to their portfolio in Q2 2025, for an estimated $4,097,203
• RENAISSANCE TECHNOLOGIES LLC added 721,900 shares (+345.7%) to their portfolio in Q2 2025, for an estimated $3,660,033
• WESTERN STANDARD LLC removed 615,433 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,120,245
• SHAOLIN CAPITAL MANAGEMENT LLC removed 379,981 shares (-59.9%) from their portfolio in Q2 2025, for an estimated $1,926,503
• OWL CREEK ASSET MANAGEMENT, L.P. removed 357,044 shares (-51.5%) from their portfolio in Q2 2025, for an estimated $1,810,213
• MORGAN STANLEY added 346,314 shares (+34631400.0%) to their portfolio in Q2 2025, for an estimated $1,755,811

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Bitcoin Depot Analyst Ratings

Wall Street analysts have issued reports on $BTM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• B. Riley Securities issued a "Buy" rating on 05/16/2025

To track analyst ratings and price targets for Bitcoin Depot, check out Quiver Quantitative's $BTM forecast page.

Bitcoin Depot Price Targets

Multiple analysts have issued price targets for $BTM recently. We have seen 2 analysts offer price targets for $BTM in the last 6 months, with a median target of $6.0.

Here are some recent targets:

• Mike Colonnese from HC Wainwright & Co. set a target price of $6.5 on 08/13/2025
• Harold Goetsch from B. Riley Securities set a target price of $5.5 on 05/16/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent chatter on X about Meta Platforms (META) has been buzzing with reactions to the company’s ongoing investments in artificial intelligence, particularly following reports of potential collaborations with Google Cloud to enhance ad capabilities. Many users are intrigued by how these AI initiatives could redefine Meta’s growth trajectory, especially with analyst upgrades like Mizuho’s recent 'Outperform' rating fueling optimism. The discussion often pivots to whether these moves will justify the hefty capital expenditures that have caused some stock volatility.

Additionally, there’s a mix of concern and curiosity surrounding Meta’s stock price fluctuations, with some on X pointing to a recent dip of over 1% as a sign of market hesitancy amid broader economic uncertainties. Others argue that the long-term outlook remains strong, citing Instagram’s milestone of 3 billion monthly active users as a testament to the company’s enduring appeal. This blend of perspectives keeps the conversation lively and dynamic.

Note: This discussion summary was generated from an AI condensation of post data.

Meta Platforms Congressional Stock Trading

Members of Congress have traded $META stock 39 times in the past 6 months. Of those trades, 26 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $META stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 11 times. They made 11 purchases worth up to $1,500,000 on 09/17, 09/10, 08/13, 08/01, 07/29, 07/17, 07/16, 06/30 and 0 sales.
• SENATOR SHELLEY MOORE CAPITO purchased up to $15,000 on 07/29.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 2 purchases worth up to $30,000 on 07/22, 07/16 and 0 sales.
• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
• REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 06/30.
• REPRESENTATIVE VAL T. HOYLE purchased up to $15,000 on 06/06.
• SENATOR JOHN BOOZMAN has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/30, 05/16, 04/15 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/14, 05/05 and 0 sales.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 6 times. They made 1 purchase worth up to $15,000 on 05/13 and 5 sales worth up to $75,000 on 04/17, 04/16, 04/02.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 0 purchases and 3 sales worth up to $550,000 on 05/12, 04/17, 04/07.
• REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 1 purchase worth up to $15,000 on 04/23 and 1 sale worth up to $15,000 on 04/16.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• REPRESENTATIVE KELLY MORRISON has traded it 2 times. They made 2 purchases worth up to $65,000 on 04/11 and 0 sales.
• REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 04/09.
• REPRESENTATIVE JULIE JOHNSON sold up to $50,000 on 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Meta Platforms Insider Trading Activity

Meta Platforms insiders have traded $META stock on the open market 353 times in the past 6 months. Of those trades, 0 have been purchases and 353 have been sales.

Here’s a breakdown of recent trading of $META stock by insiders over the last 6 months:

• MARK ZUCKERBERG (COB and CEO) has made 0 purchases and 244 sales selling 284,660 shares for an estimated $211,302,008.
• CHRISTOPHER K COX (Chief Product Officer) has made 0 purchases and 13 sales selling 75,000 shares for an estimated $58,074,139.
• ANDREW BOSWORTH (Chief Technology Officer) has made 0 purchases and 10 sales selling 44,257 shares for an estimated $30,649,180.
• SUSAN J LI (Chief Financial Officer) has made 0 purchases and 17 sales selling 32,081 shares for an estimated $23,928,207.
• JAVIER OLIVAN (Chief Operating Officer) has made 0 purchases and 32 sales selling 18,698 shares for an estimated $12,850,664.
• JENNIFER NEWSTEAD (Chief Legal Officer) has made 0 purchases and 30 sales selling 15,369 shares for an estimated $10,145,086.
• ROBERT M KIMMITT has made 0 purchases and 5 sales selling 2,335 shares for an estimated $1,676,743.
• PEGGY ALFORD has made 0 purchases and 2 sales selling 1,218 shares for an estimated $802,318.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Meta Platforms Hedge Fund Activity

We have seen 2,609 institutional investors add shares of Meta Platforms stock to their portfolio, and 1,749 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 59,766,000 shares (+608429.2%) to their portfolio in Q2 2025, for an estimated $44,112,686,940
• GAMMA INVESTING LLC removed 23,408,174 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $17,277,339,147
• NUVEEN, LLC added 9,548,268 shares (+181.9%) to their portfolio in Q2 2025, for an estimated $7,047,481,128
• JPMORGAN CHASE & CO removed 3,476,325 shares (-6.0%) from their portfolio in Q2 2025, for an estimated $2,565,840,719
• NORGES BANK removed 2,699,981 shares (-7.9%) from their portfolio in Q2 2025, for an estimated $1,992,828,976
• SG AMERICAS SECURITIES, LLC removed 2,447,490 shares (-64.7%) from their portfolio in Q2 2025, for an estimated $1,806,467,894
• BANK OF AMERICA CORP /DE/ added 2,378,320 shares (+15.5%) to their portfolio in Q2 2025, for an estimated $1,755,414,208

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Meta Platforms Analyst Ratings

Wall Street analysts have issued reports on $META in the last several months. We have seen 32 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 09/30/2025
• Cantor Fitzgerald issued a "Overweight" rating on 08/13/2025
• Wells Fargo issued a "Overweight" rating on 07/31/2025
• Benchmark issued a "Buy" rating on 07/31/2025
• Rosenblatt issued a "Buy" rating on 07/31/2025
• B of A Securities issued a "Buy" rating on 07/31/2025
• Morgan Stanley issued a "Overweight" rating on 07/31/2025

To track analyst ratings and price targets for Meta Platforms, check out Quiver Quantitative's $META forecast page.

Meta Platforms Price Targets

Multiple analysts have issued price targets for $META recently. We have seen 39 analysts offer price targets for $META in the last 6 months, with a median target of $850.0.

Here are some recent targets:

• Lloyd Walmsley from Mizuho set a target price of $925.0 on 09/30/2025
• Deepak Mathivanan from Cantor Fitzgerald set a target price of $920.0 on 09/17/2025
• Rob Sanderson from Loop Capital set a target price of $980.0 on 08/05/2025
• Ross Sandler from Barclays set a target price of $810.0 on 08/01/2025
• Michael Morris from Guggenheim set a target price of $875.0 on 07/31/2025
• Stephen Ju from UBS set a target price of $897.0 on 07/31/2025
• Thomas Champion from Piper Sandler set a target price of $880.0 on 07/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Oracle Corporation (ORCL) have been buzzing with excitement following the company’s latest earnings report, which revealed a staggering 359% increase in contracted revenue, largely tied to AI and cloud infrastructure. Many users on the platform have expressed astonishment at the projected growth, with some pointing to a reported $455 billion in future revenue as a sign of Oracle’s transformation into a key player in the AI revolution. The stock’s significant surge—up over 30% in a single day—has fueled intense conversations about the company’s strategic direction.

Additionally, posts on X have highlighted Oracle’s leadership changes and massive bond sales to fund AI infrastructure, though not all reactions are purely optimistic. Some users have noted cautious market responses, with minor pullbacks in stock price amid concerns over the reality of high-profile deals and long-term execution risks. The mix of awe and scrutiny keeps the dialogue dynamic as investors weigh Oracle’s bold moves in a rapidly evolving tech landscape.

Note: This discussion summary was generated from an AI condensation of post data.

Oracle Corporation Congressional Stock Trading

Members of Congress have traded $ORCL stock 14 times in the past 6 months. Of those trades, 7 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 3 times. They made 3 purchases worth up to $200,000 on 09/23, 09/18, 09/17 and 0 sales.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 05/08 and 2 sales worth up to $100,000 on 05/12, 04/07.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 04/16.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 04/15.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Oracle Corporation Insider Trading Activity

Oracle Corporation insiders have traded $ORCL stock on the open market 48 times in the past 6 months. Of those trades, 1 have been purchases and 47 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:

• SAFRA CATZ (Chief Executive Officer) has made 0 purchases and 31 sales selling 8,694,918 shares for an estimated $1,825,887,891.
• JEFFREY HENLEY (Vice Chairman) has made 0 purchases and 2 sales selling 400,000 shares for an estimated $76,169,016.
• MICHAEL D. SICILIA (President, Industries) has made 0 purchases and 3 sales selling 66,048 shares for an estimated $20,029,695.
• CLAYTON M. MAGOUYRK (President, OCI) has made 0 purchases and 2 sales selling 36,241 shares for an estimated $9,522,348.
• WILLIAM G PARRETT sold 11,500 shares for an estimated $3,519,000
• LEON E PANETTA has made 0 purchases and 2 sales selling 22,500 shares for an estimated $3,295,501.
• MARIA SMITH (EVP, Chief Accounting Officer) sold 10,000 shares for an estimated $2,329,897
• NAOMI O SELIGMAN has made 0 purchases and 4 sales selling 10,391 shares for an estimated $2,132,795.
• GEORGE H CONRADES sold 8,169 shares for an estimated $1,743,999
• RONA ALISON FAIRHEAD purchased 480 shares for an estimated $112,257

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Oracle Corporation Hedge Fund Activity

We have seen 1,823 institutional investors add shares of Oracle Corporation stock to their portfolio, and 1,371 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FISHER ASSET MANAGEMENT, LLC removed 8,714,141 shares (-49.5%) from their portfolio in Q2 2025, for an estimated $1,905,172,646
• FMR LLC removed 7,143,518 shares (-22.3%) from their portfolio in Q2 2025, for an estimated $1,561,787,340
• NORGES BANK added 6,255,302 shares (+47.0%) to their portfolio in Q2 2025, for an estimated $1,367,596,676
• FRANKLIN RESOURCES INC removed 6,076,996 shares (-38.1%) from their portfolio in Q2 2025, for an estimated $1,328,613,635
• VICTORY CAPITAL MANAGEMENT INC added 5,925,776 shares (+683.5%) to their portfolio in Q2 2025, for an estimated $1,295,552,406
• AMUNDI removed 5,486,321 shares (-43.1%) from their portfolio in Q2 2025, for an estimated $1,199,474,360
• GAMMA INVESTING LLC removed 4,718,819 shares (-99.2%) from their portfolio in Q2 2025, for an estimated $1,031,675,397

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Oracle Corporation Government Contracts

We have seen $647,073,623 of award payments to $ORCL over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• IGF::OT::IGF TASK ORDER 36C10B18N0003 UNDER IDIQ CONTRACT 36C10B18D5000 FOR OPERATIONAL MANAGEMENT SERVICES...: $217,811,814
• EHRM OPERATIONS: $113,079,612
• EHRM LICENSES AND FEES: $97,806,309
• FORMALLY RECOGNIZE THE CONTRACTORS CORPORATE NAME CHANGE FROM CERNER GOVERNMENT SERVICES INC. TO ORACLE HEA...: $80,661,198
• THIS TASK ORDER PROVIDES ENTERPRISE PROGRAM AND PROJECT MANAGEMENT SUPPORT SERVICES FOR THE VA EHRM SYSTEM....: $39,408,972

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Oracle Corporation Analyst Ratings

Wall Street analysts have issued reports on $ORCL in the last several months. We have seen 21 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Bernstein issued a "Outperform" rating on 09/26/2025
• Rothschild & Co issued a "Sell" rating on 09/25/2025
• JMP Securities issued a "Market Outperform" rating on 09/24/2025
• Barclays issued a "Overweight" rating on 09/11/2025
• UBS issued a "Buy" rating on 09/10/2025
• Mizuho issued a "Outperform" rating on 09/10/2025
• Cantor Fitzgerald issued a "Overweight" rating on 09/10/2025

To track analyst ratings and price targets for Oracle Corporation, check out Quiver Quantitative's $ORCL forecast page.

Oracle Corporation Price Targets

Multiple analysts have issued price targets for $ORCL recently. We have seen 28 analysts offer price targets for $ORCL in the last 6 months, with a median target of $346.0.

Here are some recent targets:

• Mark L. Moerdler from Bernstein set a target price of $364.0 on 09/26/2025
• Alex Haissl from Rothschild & Co set a target price of $175.0 on 09/25/2025
• Patrick Walravens from JMP Securities set a target price of $342.0 on 09/24/2025
• Keith Weiss from Morgan Stanley set a target price of $320.0 on 09/23/2025
• Nay Soe Naing from Berenberg set a target price of $306.0 on 09/15/2025
• Kash Rangan from Goldman Sachs set a target price of $310.0 on 09/15/2025
• Gil Luria from DA Davidson set a target price of $300.0 on 09/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Tempus AI, Inc. (TEM) have been fueled by the company's FDA 510(k) clearance for its RNA-based xR IVD device, a significant step in advancing clinical diagnostics. Many users are highlighting the potential for this milestone to drive future growth, especially as it aligns with the firm's focus on AI-driven healthcare solutions. The conversation also touches on raised analyst targets and the stock's technical momentum, sparking interest among traders.

Additionally, there’s notable attention on recent insider activity, particularly the CEO's sale of shares, which has led to mixed reactions on the platform. While some express concern over the timing and scale of the transaction, others remain focused on positive fundamentals like revenue growth and the 2025 outlook. This duality keeps the dialogue dynamic as investors weigh risks against long-term potential.

Note: This discussion summary was generated from an AI condensation of post data.

Tempus AI, Inc. Insider Trading Activity

Tempus AI, Inc. insiders have traded $TEM stock on the open market 101 times in the past 6 months. Of those trades, 0 have been purchases and 101 have been sales.

Here’s a breakdown of recent trading of $TEM stock by insiders over the last 6 months:

• ERIC P LEFKOFSKY (CEO and Chairman) has made 0 purchases and 44 sales selling 1,365,460 shares for an estimated $97,784,895.
• RYAN FUKUSHIMA (Chief Operating Officer) has made 0 purchases and 17 sales selling 80,280 shares for an estimated $5,148,795.
• THEODORE LEONSIS has made 0 purchases and 3 sales selling 64,770 shares for an estimated $4,643,220.
• ERIK PHELPS (EVP & Chief Admin & Legal Off) has made 0 purchases and 8 sales selling 63,396 shares for an estimated $4,529,084.
• JAMES WILLIAM ROGERS (Chief Financial Officer) has made 0 purchases and 9 sales selling 30,649 shares for an estimated $2,024,803.
• ANDREW POLOVIN (EVP and General Counsel) has made 0 purchases and 9 sales selling 24,373 shares for an estimated $1,619,008.
• RYAN M BARTOLUCCI (Chief Accounting Officer) has made 0 purchases and 5 sales selling 7,977 shares for an estimated $526,163.
• DAVID R EPSTEIN has made 0 purchases and 4 sales selling 1,240 shares for an estimated $72,414.
• JENNIFER A DOUDNA has made 0 purchases and 2 sales selling 1,183 shares for an estimated $69,876.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Tempus AI, Inc. Government Contracts

We have seen $18,460,020 of award payments to $TEM over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• ADAPT CRO SUPPORT SERVICES SOLICITATION: $12,741,975
• TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES: $5,718,045

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Tempus AI, Inc. Analyst Ratings

Wall Street analysts have issued reports on $TEM in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 09/26/2025
• HC Wainwright & Co. issued a "Buy" rating on 09/02/2025
• BTIG issued a "Buy" rating on 08/20/2025
• Morgan Stanley issued a "Overweight" rating on 08/12/2025
• Needham issued a "Buy" rating on 05/07/2025

To track analyst ratings and price targets for Tempus AI, Inc., check out Quiver Quantitative's $TEM forecast page.

Tempus AI, Inc. Price Targets

Multiple analysts have issued price targets for $TEM recently. We have seen 7 analysts offer price targets for $TEM in the last 6 months, with a median target of $70.0.

Here are some recent targets:

• Subbu Nambi from Guggenheim set a target price of $95.0 on 09/26/2025
• Yi Chen from HC Wainwright & Co. set a target price of $98.0 on 09/12/2025
• Mark Massaro from BTIG set a target price of $85.0 on 08/20/2025
• Tejas Savant from Morgan Stanley set a target price of $68.0 on 08/12/2025
• Michael Ryskin from B of A Securities set a target price of $70.0 on 06/25/2025
• David Westenberg from Piper Sandler set a target price of $70.0 on 05/15/2025
• Ryan MacDonald from Needham set a target price of $70.0 on 05/07/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Palantir Technologies (PLTR) have been ignited by the company's impressive stock performance and strategic partnerships, particularly in the AI and defense sectors. Many users are pointing to the stock's significant gains, with some noting a year-to-date increase of over 140%, as a sign of strong market confidence in Palantir's growth trajectory. There's also chatter about recent collaborations, such as a notable partnership with Boeing for AI integration, which has further fueled optimism.

However, not all sentiments are uniformly positive, as some voices on X express caution over the stock's high valuation and potential volatility ahead of upcoming earnings reports. Concerns linger about whether the current price adequately reflects the company's fundamentals, with a few users anticipating a sharp move—up or down—post-earnings. This mix of excitement and apprehension keeps the conversation around PLTR dynamic and closely watched.

Note: This discussion summary was generated from an AI condensation of post data.

Palantir Technologies Congressional Stock Trading

Members of Congress have traded $PLTR stock 12 times in the past 6 months. Of those trades, 10 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $PLTR stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 5 times. They made 5 purchases worth up to $565,000 on 08/13, 07/28, 07/18, 06/30, 06/25 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 07/15, 04/09, 04/08 and 0 sales.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 06/30.
• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $100,000 on 05/12.
• REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Palantir Technologies Insider Trading Activity

Palantir Technologies insiders have traded $PLTR stock on the open market 242 times in the past 6 months. Of those trades, 1 have been purchases and 241 have been sales.

Here’s a breakdown of recent trading of $PLTR stock by insiders over the last 6 months:

• SHYAM SANKAR (See Remarks) has made 0 purchases and 51 sales selling 1,148,406 shares for an estimated $162,350,255.
• ALEXANDER C. KARP (See Remarks) has made 0 purchases and 25 sales selling 807,879 shares for an estimated $113,126,187.
• STEPHEN ANDREW COHEN (See Remarks) has made 0 purchases and 25 sales selling 695,937 shares for an estimated $97,437,425.
• RYAN D. TAYLOR (See Remarks) has made 0 purchases and 29 sales selling 192,371 shares for an estimated $28,552,617.
• DAVID A. GLAZER (See Remarks) has made 0 purchases and 33 sales selling 132,910 shares for an estimated $19,548,233.
• ALEXANDER D. MOORE has made 0 purchases and 31 sales selling 100,000 shares for an estimated $13,723,236.
• LAUREN ELAINA FRIEDMAN STAT has made 0 purchases and 7 sales selling 31,600 shares for an estimated $5,259,954.
• ERIC H. WOERSCHING has made 0 purchases and 14 sales selling 27,214 shares for an estimated $3,535,530.
• HEATHER A. PLANISHEK purchased 10,000 shares for an estimated $1,161,400
• JEFFREY BUCKLEY (See Remarks) has made 0 purchases and 26 sales selling 7,065 shares for an estimated $1,042,459.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Palantir Technologies Hedge Fund Activity

We have seen 1,609 institutional investors add shares of Palantir Technologies stock to their portfolio, and 827 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 18,661,152 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,543,888,240
• BLACKROCK, INC. removed 11,014,628 shares (-5.9%) from their portfolio in Q2 2025, for an estimated $1,501,514,088
• JPMORGAN CHASE & CO removed 7,716,375 shares (-32.4%) from their portfolio in Q2 2025, for an estimated $1,051,896,240
• VANGUARD GROUP INC added 7,194,216 shares (+3.6%) to their portfolio in Q2 2025, for an estimated $980,715,525
• NORGES BANK added 6,277,645 shares (+34.9%) to their portfolio in Q2 2025, for an estimated $855,768,566
• STATE STREET CORP added 6,097,629 shares (+6.9%) to their portfolio in Q2 2025, for an estimated $831,228,785
• GEODE CAPITAL MANAGEMENT, LLC removed 5,723,603 shares (-10.3%) from their portfolio in Q2 2025, for an estimated $780,241,560

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Palantir Technologies Government Contracts

We have seen $695,873,923 of award payments to $PLTR over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• TASK ORDER #1 FOR MAVEN SMART SYSTEM - USER INTERFACE/USER EXPERIENCE (UI/UX) PROTOTYPE: $133,292,753
• INVESTIGATIVE CASE MANAGEMENT (ICM) OPERATIONS AND MAINTENANCE (O&M) SUPPORT SERVICES AND CUSTOM ENHANCEMENTS: $81,116,690
• SOFTWARE AS A SERVICE (SAAS) MODEL OF ARMY VANTAGE ON BEHALF OF PEO EIS, PDM ADP. ARMY VANTAGE IS THE ARMY'...: $55,758,778
• ESTABLISH BASIC LETTER CONTRACT FOR COMMERCIAL DATA AS A SERVE PLATFORM.: $48,101,169
• TASK ORDER OFF A COMMERCIAL SOLUTIONS OPENING (CSO) FOR RESEARCH AND DEVELOPMENT FOR MAVEN SMART SYSTEM (MS...: $41,544,391

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Palantir Technologies Analyst Ratings

Wall Street analysts have issued reports on $PLTR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• RBC Capital issued a "Underperform" rating on 08/05/2025
• B of A Securities issued a "Buy" rating on 08/05/2025
• Piper Sandler issued a "Overweight" rating on 08/05/2025
• Loop Capital issued a "Buy" rating on 07/30/2025
• Mizuho issued a "Underperform" rating on 06/11/2025

To track analyst ratings and price targets for Palantir Technologies, check out Quiver Quantitative's $PLTR forecast page.

Palantir Technologies Price Targets

Multiple analysts have issued price targets for $PLTR recently. We have seen 13 analysts offer price targets for $PLTR in the last 6 months, with a median target of $165.0.

Here are some recent targets:

• Mariana Perez Mora from B of A Securities set a target price of $215.0 on 09/23/2025
• Gabriela Borges from Goldman Sachs set a target price of $141.0 on 08/06/2025
• Brent Bracelin from Piper Sandler set a target price of $182.0 on 08/05/2025
• Brad Zelnick from Deutsche Bank set a target price of $160.0 on 08/05/2025
• Tyler Radke from Citigroup set a target price of $177.0 on 08/05/2025
• Mark Schappel from Loop Capital set a target price of $180.0 on 08/05/2025
• Sanjit Singh from Morgan Stanley set a target price of $155.0 on 08/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Broadcom Inc. (AVGO) have been buzzing with excitement over the company's remarkable growth in the AI sector. Many users are pointing to the firm's significant revenue increases from AI-related services, with some noting impressive year-over-year gains as a key driver of interest. The chatter also frequently mentions analyst upgrades and raised price targets, adding fuel to the optimistic outlook surrounding the stock.

Additionally, there’s a focus on Broadcom’s recent quarterly earnings, which have reportedly exceeded expectations, alongside forward-looking guidance that suggests sustained momentum. Some voices on X have raised concerns about potential pullbacks if negative developments arise, particularly around delays in AI chip rollouts. Still, the conversation remains dynamic, with a strong emphasis on the company's long-term potential in AI and semiconductors.

Note: This discussion summary was generated from an AI condensation of post data.

Broadcom Inc. Congressional Stock Trading

Members of Congress have traded $AVGO stock 26 times in the past 6 months. Of those trades, 17 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $AVGO stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 6 times. They made 6 purchases worth up to $315,000 on 09/17, 08/15, 08/13, 07/29, 07/18 and 0 sales.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 07/18.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
• REPRESENTATIVE JAMES COMER sold up to $15,000 on 07/03.
• REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 06/25.
• REPRESENTATIVE NANCY PELOSI purchased up to $5,000,000 on 06/20.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/17, 06/11 and 1 sale worth up to $15,000 on 06/10.
• SENATOR JOHN BOOZMAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/11, 04/08 and 0 sales.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/11 and 1 sale worth up to $15,000 on 04/03.
• REPRESENTATIVE VAL T. HOYLE purchased up to $15,000 on 06/06.
• REPRESENTATIVE DAVID TAYLOR purchased up to $15,000 on 05/14.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 0 purchases and 2 sales worth up to $300,000 on 05/12, 04/17.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• REPRESENTATIVE KELLY MORRISON has traded it 2 times. They made 2 purchases worth up to $65,000 on 04/11 and 0 sales.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Broadcom Inc. Insider Trading Activity

Broadcom Inc. insiders have traded $AVGO stock on the open market 97 times in the past 6 months. Of those trades, 3 have been purchases and 94 have been sales.

Here’s a breakdown of recent trading of $AVGO stock by insiders over the last 6 months:

• HENRY SAMUELI has made 0 purchases and 13 sales selling 842,695 shares for an estimated $250,357,760.
• HOCK E TAN (President and CEO) has made 0 purchases and 6 sales selling 445,912 shares for an estimated $134,838,216.
• MARK DAVID BRAZEAL (Chief Legal & Corp Affairs Ofc) has made 0 purchases and 27 sales selling 152,204 shares for an estimated $39,861,686.
• KIRSTEN M. SPEARS (CFO & Chief Accounting Officer) has made 0 purchases and 21 sales selling 104,979 shares for an estimated $28,017,294.
• CHARLIE B KAWWAS (President, Semi Solutions Grp) has made 0 purchases and 20 sales selling 16,397 shares for an estimated $4,785,269.
• JUSTINE PAGE has made 0 purchases and 6 sales selling 4,800 shares for an estimated $1,285,840.
• HARRY L. YOU has made 3 purchases buying 3,550 shares for an estimated $1,227,870 and 0 sales.
• GAYLA J DELLY sold 3,000 shares for an estimated $795,390

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Broadcom Inc. Hedge Fund Activity

We have seen 2,182 institutional investors add shares of Broadcom Inc. stock to their portfolio, and 1,610 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GAMMA INVESTING LLC removed 17,161,157 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $4,730,472,927
• FMR LLC added 15,242,268 shares (+15.0%) to their portfolio in Q2 2025, for an estimated $4,201,531,174
• PRICE T ROWE ASSOCIATES INC /MD/ added 12,640,424 shares (+19.3%) to their portfolio in Q2 2025, for an estimated $3,484,332,875
• CAPITAL INTERNATIONAL INVESTORS removed 12,484,722 shares (-7.6%) from their portfolio in Q2 2025, for an estimated $3,441,413,619
• JANE STREET GROUP, LLC removed 7,333,469 shares (-97.8%) from their portfolio in Q2 2025, for an estimated $2,021,470,729
• CAPITAL WORLD INVESTORS removed 6,799,578 shares (-4.4%) from their portfolio in Q2 2025, for an estimated $1,874,303,675
• VANGUARD GROUP INC added 6,222,802 shares (+1.3%) to their portfolio in Q2 2025, for an estimated $1,715,315,371

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Broadcom Inc. Government Contracts

We have seen $66,916,541 of award payments to $AVGO over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• NEW 66 MONTH OPEN-MARKET CONTRACT FOR RENEWAL OF CA SOFTWARE, SUPPORT SERVICES, AND MAINTENANCE. CA PROPRIE...: $41,249,999
• CA SOFTWARE MAINTENANCE: $21,091,011
• BROADCOM TECHNICAL SUPPORT SERVICES INDEFINITE DELIVERY/INDEFINITE QUANTITY (IDIQ) CONTRACT - TASK ORDER F...: $3,629,376
• BROADCOM TECHNICAL SUPPORT SERVICES INDEFINITE DELIVERY/INDEFINITE QUANTITY (IDIQ) CONTRACT - TASK ORDER F...: $728,962
• BROADCOM TECHNICAL SUPPORT SERVICES INDEFINITE DELIVERY/INDEFINITE QUANTITY (IDIQ) CONTRACT - TASK ORDER F...: $170,880

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Broadcom Inc. Analyst Ratings

Wall Street analysts have issued reports on $AVGO in the last several months. We have seen 20 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Keybanc issued a "Overweight" rating on 09/30/2025
• Macquarie issued a "Outperform" rating on 09/15/2025
• Mizuho issued a "Outperform" rating on 09/12/2025
• Argus Research issued a "Buy" rating on 09/08/2025
• Evercore ISI Group issued a "Outperform" rating on 09/05/2025
• Barclays issued a "Overweight" rating on 09/05/2025
• Citigroup issued a "Buy" rating on 09/05/2025

To track analyst ratings and price targets for Broadcom Inc., check out Quiver Quantitative's $AVGO forecast page.

Broadcom Inc. Price Targets

Multiple analysts have issued price targets for $AVGO recently. We have seen 25 analysts offer price targets for $AVGO in the last 6 months, with a median target of $370.0.

Here are some recent targets:

• John Vinh from Keybanc set a target price of $420.0 on 09/30/2025
• Arthur Lai from Macquarie set a target price of $420.0 on 09/15/2025
• Vijay Rakesh from Mizuho set a target price of $410.0 on 09/12/2025
• Jim Kelleher from Argus Research set a target price of $375.0 on 09/08/2025
• Joseph Moore from Morgan Stanley set a target price of $382.0 on 09/05/2025
• Harlan Sur from JP Morgan set a target price of $400.0 on 09/05/2025
• Ross Seymore from Deutsche Bank set a target price of $350.0 on 09/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about AST SpaceMobile (ASTS) have centered around the company's latest satellite launch updates, particularly the completion of the BlueBird 6 satellite, which sparked a notable pre-market surge in the stock price. Many users on the platform are expressing excitement over the company's progress in building a space-based cellular broadband network, with some highlighting partnerships with major telecom players like AT&T and Verizon as a sign of strong future potential. The chatter reflects a high level of retail investor interest, with frequent mentions of upcoming milestones and analyst upgrades fueling the conversation.

However, not all sentiments are uniformly positive, as some discussions on X point to concerns over recent stock price volatility, with a significant drop noted in the past week, and lingering questions about technical challenges and competition from giants like SpaceX. Despite these concerns, optimism appears to dominate, with posts often citing analyst price target increases, such as a recent jump to $60 by a major financial institution, as a reason for continued confidence. The dynamic mix of hope and caution keeps the dialogue around ASTS lively and engaging.

Note: This discussion summary was generated from an AI condensation of post data.

AST SpaceMobile Insider Trading Activity

AST SpaceMobile insiders have traded $ASTS stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $ASTS stock by insiders over the last 6 months:

• HUIWEN YAO (Chief Technology Officer) has made 0 purchases and 3 sales selling 111,000 shares for an estimated $3,866,940.
• SCOTT WISNIEWSKI (President) sold 50,000 shares for an estimated $1,782,500
• ANDREW MARTIN JOHNSON (CFO and CLO) sold 20,000 shares for an estimated $1,049,600
• SHANTI B. GUPTA (Chief Operating Officer) has made 0 purchases and 2 sales selling 25,000 shares for an estimated $959,600.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AST SpaceMobile Hedge Fund Activity

We have seen 237 institutional investors add shares of AST SpaceMobile stock to their portfolio, and 131 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 3,107,100 shares (+21.5%) to their portfolio in Q2 2025, for an estimated $145,194,783
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,185,894 shares (-92.3%) from their portfolio in Q2 2025, for an estimated $102,146,826
• GOLDMAN SACHS GROUP INC removed 2,027,579 shares (-67.8%) from their portfolio in Q2 2025, for an estimated $94,748,766
• CITADEL ADVISORS LLC removed 1,900,151 shares (-93.3%) from their portfolio in Q2 2025, for an estimated $88,794,056
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,318,304 shares (+107.7%) to their portfolio in Q2 2025, for an estimated $61,604,345
• BLACKROCK, INC. removed 1,312,374 shares (-11.4%) from their portfolio in Q2 2025, for an estimated $61,327,237
• MORGAN STANLEY added 1,025,315 shares (+32.8%) to their portfolio in Q2 2025, for an estimated $47,912,969

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AST SpaceMobile Analyst Ratings

Wall Street analysts have issued reports on $ASTS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 10/01/2025
• B. Riley Securities issued a "Buy" rating on 06/16/2025

To track analyst ratings and price targets for AST SpaceMobile, check out Quiver Quantitative's $ASTS forecast page.

AST SpaceMobile Price Targets

Multiple analysts have issued price targets for $ASTS recently. We have seen 5 analysts offer price targets for $ASTS in the last 6 months, with a median target of $44.0.

Here are some recent targets:

• Mathieu Robilliard from Barclays set a target price of $60.0 on 10/01/2025
• Christopher Schoell from UBS set a target price of $43.0 on 09/09/2025
• Andres Coello from Scotiabank set a target price of $42.9 on 08/07/2025
• Michael Funk from B of A Securities set a target price of $55.0 on 06/25/2025
• Mike Crawford from B. Riley Securities set a target price of $44.0 on 06/16/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent chatter on X about Oklo Inc. (OKLO) has been lively, with much of the focus on the company’s role in the nuclear energy sector amid growing energy demands from AI and data centers. Many discussions highlight strategic partnerships and potential regulatory tailwinds as catalysts for the stock’s dramatic price swings. The narrative often centers on nuclear power as a key solution for sustainable energy, sparking intense interest.

However, not all sentiments are optimistic, as skepticism persists around regulatory hurdles and the company’s timeline to profitability. Some voices on X point to the speculative nature of the stock, citing concerns over past rejections by the Nuclear Regulatory Commission and the lack of current revenue. This divide in opinions keeps the conversation dynamic and polarizing.

Note: This discussion summary was generated from an AI condensation of post data.

Oklo Inc. Insider Trading Activity

Oklo Inc. insiders have traded $OKLO stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $OKLO stock by insiders over the last 6 months:

• MICHAEL STUART KLEIN has made 0 purchases and 7 sales selling 350,000 shares for an estimated $25,194,839.
• RICHARD CRAIG BEALMEAR (Chief Financial Officer) has made 0 purchases and 3 sales selling 100,000 shares for an estimated $9,431,387.
• WILLIAM CARROLL MURPHY GOODWIN (Chief Legal & Strategy Officer) sold 41,387 shares for an estimated $2,900,901

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Oklo Inc. Hedge Fund Activity

We have seen 361 institutional investors add shares of Oklo Inc. stock to their portfolio, and 114 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. added 5,839,676 shares (+395.2%) to their portfolio in Q2 2025, for an estimated $326,963,459
• VANGUARD GROUP INC added 4,310,162 shares (+98.4%) to their portfolio in Q2 2025, for an estimated $241,325,970
• STATE STREET CORP added 1,752,946 shares (+454.5%) to their portfolio in Q2 2025, for an estimated $98,147,446
• GEODE CAPITAL MANAGEMENT, LLC added 1,488,482 shares (+195.9%) to their portfolio in Q2 2025, for an estimated $83,340,107
• EXODUSPOINT CAPITAL MANAGEMENT, LP added 1,367,968 shares (+1095.2%) to their portfolio in Q2 2025, for an estimated $76,592,528
• D. E. SHAW & CO., INC. added 1,187,223 shares (+inf%) to their portfolio in Q2 2025, for an estimated $66,472,615
• RENAISSANCE TECHNOLOGIES LLC removed 1,096,400 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $61,387,436

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Oklo Inc. Analyst Ratings

Wall Street analysts have issued reports on $OKLO in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 09/29/2025
• Wedbush issued a "Outperform" rating on 09/22/2025
• HC Wainwright & Co. issued a "Buy" rating on 08/12/2025
• Cantor Fitzgerald issued a "Overweight" rating on 07/15/2025
• William Blair issued a "Outperform" rating on 05/28/2025
• CLSA issued a "Outperform" rating on 05/27/2025

To track analyst ratings and price targets for Oklo Inc., check out Quiver Quantitative's $OKLO forecast page.

Oklo Inc. Price Targets

Multiple analysts have issued price targets for $OKLO recently. We have seen 11 analysts offer price targets for $OKLO in the last 6 months, with a median target of $90.0.

Here are some recent targets:

• Dimple Gosai from B of A Securities set a target price of $117.0 on 09/30/2025
• An analyst from Barclays set a target price of $146.0 on 09/29/2025
• Brian Lee from Goldman Sachs set a target price of $117.0 on 09/25/2025
• Daniel Ives from Wedbush set a target price of $150.0 on 09/22/2025
• Jon Windham from UBS set a target price of $65.0 on 08/20/2025
• Sameer Joshi from HC Wainwright & Co. set a target price of $90.0 on 08/12/2025
• Vikram Bagri from Citigroup set a target price of $68.0 on 07/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Vistra Corp (VST) have been notably active, centering on the stock's significant price rally and its strategic positioning in the energy sector. Many users are captivated by the company's reported gains, often linking the surge to rising electricity demand driven by AI and data centers. Analyst upgrades and strong earnings reports have further fueled the conversation, keeping the stock in the spotlight.

Additionally, there’s a focus on Vistra’s recent moves in natural gas and battery storage expansions, with some on X expressing optimism about the potential for long-term growth. The chatter also reflects curiosity about whether the stock can maintain its momentum amid recent volatility. These discussions highlight the intersection of technological trends and energy demands as key drivers of interest in Vistra.

Note: This discussion summary was generated from an AI condensation of post data.

Vistra Corp Congressional Stock Trading

Members of Congress have traded $VST stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $VST stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Vistra Corp Insider Trading Activity

Vistra Corp insiders have traded $VST stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.

Here’s a breakdown of recent trading of $VST stock by insiders over the last 6 months:

• JAMES A BURKE (President and CEO) has made 0 purchases and 20 sales selling 319,073 shares for an estimated $66,162,161.
• KRISTOPHER E. MOLDOVAN (EVP and CFO) has made 0 purchases and 4 sales selling 139,925 shares for an estimated $21,990,390.
• CARRIE LEE KIRBY (EVP and Chief Admin. Officer) has made 0 purchases and 2 sales selling 108,000 shares for an estimated $16,953,596.
• SCOTT B HELM has made 0 purchases and 2 sales selling 70,000 shares for an estimated $11,773,360.
• SCOTT A HUDSON (EVP & President Vistra Retail) sold 56,000 shares for an estimated $8,792,000
• STEPHANIE ZAPATA MOORE (EVP and General Counsel) sold 35,000 shares for an estimated $5,650,225
• JOHN R SULT sold 25,000 shares for an estimated $4,291,675

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Vistra Corp Hedge Fund Activity

We have seen 749 institutional investors add shares of Vistra Corp stock to their portfolio, and 494 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 4,845,041 shares (+120.6%) to their portfolio in Q2 2025, for an estimated $939,017,396
• CASTLE HOOK PARTNERS LP added 2,402,811 shares (+255.3%) to their portfolio in Q2 2025, for an estimated $465,688,799
• LONE PINE CAPITAL LLC added 1,864,931 shares (+40.5%) to their portfolio in Q2 2025, for an estimated $361,442,277
• NORGES BANK added 1,831,733 shares (+61.7%) to their portfolio in Q2 2025, for an estimated $355,008,172
• FMR LLC added 1,815,562 shares (+10.5%) to their portfolio in Q2 2025, for an estimated $351,874,071
• POINT72 ASSET MANAGEMENT, L.P. removed 1,346,956 shares (-85.5%) from their portfolio in Q2 2025, for an estimated $261,053,542
• NUVEEN, LLC added 1,181,767 shares (+66.4%) to their portfolio in Q2 2025, for an estimated $229,038,262

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Vistra Corp Analyst Ratings

Wall Street analysts have issued reports on $VST in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 09/25/2025
• JP Morgan issued a "Overweight" rating on 09/24/2025
• UBS issued a "Buy" rating on 07/25/2025

To track analyst ratings and price targets for Vistra Corp, check out Quiver Quantitative's $VST forecast page.

Vistra Corp Price Targets

Multiple analysts have issued price targets for $VST recently. We have seen 7 analysts offer price targets for $VST in the last 6 months, with a median target of $230.0.

Here are some recent targets:

• Stephen Byrd from Morgan Stanley set a target price of $223.0 on 09/25/2025
• Jeremy Tonet from JP Morgan set a target price of $248.0 on 09/24/2025
• Julien Dumoulin-Smith from Jefferies set a target price of $230.0 on 09/23/2025
• Andrew Weisel from Scotiabank set a target price of $256.0 on 09/22/2025
• Carly Davenport from Goldman Sachs set a target price of $203.0 on 08/13/2025
• James Thalacker from BMO Capital set a target price of $229.0 on 08/12/2025
• William Appicelli from UBS set a target price of $230.0 on 07/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Nike (NKE) have centered on the company’s latest quarterly earnings report, which showed a surprising revenue increase and a significant earnings beat, despite ongoing challenges. Many users expressed cautious optimism, pointing to improved sales figures and inventory management as signs of a potential turnaround for the sportswear giant. However, concerns linger over weak demand in China and the impact of rising tariffs on margins.

Conversations also highlighted the return of a former executive as CEO, with some on X speculating that this leadership change could steer Nike back to stronger growth. There’s a mix of relief over the earnings beat and skepticism about the sustainability of the recovery, especially with warnings of a sluggish holiday season. The dialogue reflects a critical moment for Nike as it navigates these complex headwinds.

Note: This discussion summary was generated from an AI condensation of post data.

Nike Congressional Stock Trading

Members of Congress have traded $NKE stock 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $NKE stock by members of Congress over the last 6 months:

• REPRESENTATIVE KELLY MORRISON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 06/04.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 04/10.
• REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/08, 04/04 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Nike Insider Trading Activity

Nike insiders have traded $NKE stock on the open market 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $NKE stock by insiders over the last 6 months:

• MARK G PARKER (EXECUTIVE CHAIRMAN) has made 0 purchases and 2 sales selling 196,078 shares for an estimated $14,487,802.
• ROBERT HOLMES SWAN purchased 8,600 shares for an estimated $502,756
• PHILIP MCCARTNEY (EVP: CHIEF INN,PROD&DSG OFCR) sold 3,162 shares for an estimated $244,138
• ROBERT LEINWAND (EVP: Chief Legal Officer) has made 0 purchases and 2 sales selling 2,663 shares for an estimated $199,210.
• JOHANNA NIELSEN (VP: CORP CONTROLLER) sold 138 shares for an estimated $7,977

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Nike Hedge Fund Activity

We have seen 894 institutional investors add shares of Nike stock to their portfolio, and 1,086 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP removed 13,082,482 shares (-28.8%) from their portfolio in Q2 2025, for an estimated $929,379,521
• GOLDMAN SACHS GROUP INC removed 11,111,376 shares (-41.6%) from their portfolio in Q2 2025, for an estimated $789,352,151
• FMR LLC added 9,971,384 shares (+66.8%) to their portfolio in Q2 2025, for an estimated $708,367,119
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 8,809,950 shares (+3129.9%) to their portfolio in Q2 2025, for an estimated $625,858,848
• HARRIS ASSOCIATES L P added 8,748,943 shares (+inf%) to their portfolio in Q2 2025, for an estimated $621,524,910
• WELLS FARGO & COMPANY/MN removed 7,389,887 shares (-54.2%) from their portfolio in Q2 2025, for an estimated $524,977,572
• TWO SIGMA ADVISERS, LP added 5,340,000 shares (+8066.5%) to their portfolio in Q2 2025, for an estimated $379,353,600

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Nike Analyst Ratings

Wall Street analysts have issued reports on $NKE in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 10/01/2025
• Truist Securities issued a "Buy" rating on 10/01/2025
• Piper Sandler issued a "Overweight" rating on 10/01/2025
• JP Morgan issued a "Overweight" rating on 10/01/2025
• RBC Capital issued a "Outperform" rating on 09/18/2025
• TD Cowen issued a "Buy" rating on 09/10/2025
• Argus Research issued a "Buy" rating on 07/01/2025

To track analyst ratings and price targets for Nike, check out Quiver Quantitative's $NKE forecast page.

Nike Price Targets

Multiple analysts have issued price targets for $NKE recently. We have seen 20 analysts offer price targets for $NKE in the last 6 months, with a median target of $79.5.

Here are some recent targets:

• Joseph Civello from Truist Securities set a target price of $85.0 on 10/01/2025
• Jim Duffy from Stifel set a target price of $68.0 on 10/01/2025
• Tom Nikic from Needham set a target price of $78.0 on 10/01/2025
• Adrienne Yih from Barclays set a target price of $70.0 on 10/01/2025
• Anna Andreeva from Piper Sandler set a target price of $84.0 on 10/01/2025
• Matthew Boss from JP Morgan set a target price of $100.0 on 10/01/2025
• Cristina Fernandez from Telsey Advisory Group set a target price of $75.0 on 10/01/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about BigBear.ai Holdings (BBAI) have centered around the company's volatile stock performance and its position in the defense AI sector. Many users have pointed out the stock's significant year-to-date gains of over 60%, fueled by growing interest in AI-driven solutions, though some express skepticism about its competitive standing against larger players. A notable buzz has also emerged from reports of government contracts and insider buying, which have sparked curiosity among retail investors.

Despite the enthusiasm, there are concerns circulating on the platform regarding recent price drops, with some attributing the declines to broader market warnings and perceived weaknesses in the company's fundamentals. Posts on X highlight a divide, with a faction of users viewing the dips as potential entry points, while others caution against over-optimism given past earnings misses. The conversation remains dynamic as investors weigh the promise of AI innovation against execution risks.

Note: This discussion summary was generated from an AI condensation of post data.

BigBear.ai Holdings Congressional Stock Trading

Members of Congress have traded $BBAI stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BBAI stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN purchased up to $50,000 on 08/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BigBear.ai Holdings Insider Trading Activity

BigBear.ai Holdings insiders have traded $BBAI stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $BBAI stock by insiders over the last 6 months:

• ULTIMATE HOLDINGS, LLC PANGIAM sold 27,430,402 shares for an estimated $78,450,949
• JULIE PEFFER (Chief Financial Officer) has made 0 purchases and 5 sales selling 115,924 shares for an estimated $445,078.
• DOROTHY D HAYES has made 0 purchases and 2 sales selling 56,000 shares for an estimated $268,500.
• SEAN RAYMOND RICKER (Chief Financial Officer) has made 0 purchases and 6 sales selling 73,315 shares for an estimated $250,189.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BigBear.ai Holdings Hedge Fund Activity

We have seen 192 institutional investors add shares of BigBear.ai Holdings stock to their portfolio, and 67 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AE INDUSTRIAL PARTNERS, LP removed 27,430,402 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $186,252,429
• VANGUARD GROUP INC added 14,488,375 shares (+229.0%) to their portfolio in Q2 2025, for an estimated $98,376,066
• BLACKROCK, INC. added 12,107,360 shares (+150.9%) to their portfolio in Q2 2025, for an estimated $82,208,974
• JUMP FINANCIAL, LLC added 5,509,104 shares (+inf%) to their portfolio in Q2 2025, for an estimated $37,406,816
• CITADEL ADVISORS LLC added 5,177,098 shares (+420.1%) to their portfolio in Q2 2025, for an estimated $35,152,495
• RENAISSANCE TECHNOLOGIES LLC added 3,933,500 shares (+243.6%) to their portfolio in Q2 2025, for an estimated $26,708,465
• UBS GROUP AG removed 2,900,065 shares (-71.1%) from their portfolio in Q2 2025, for an estimated $19,691,441

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BigBear.ai Holdings Government Contracts

We have seen $3,093,003 of award payments to $BBAI over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• COMMERICAL SOLUTIONS OPENING (CSO) FROM TRADEWINDS SOLUTIONS MARKETPLACE FOR THE ORION DECISION SUPPORT PLA...: $2,400,114
• BUSINESS REQUIREMENT SUPPORT: $692,889

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

BigBear.ai Holdings Analyst Ratings

Wall Street analysts have issued reports on $BBAI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 08/12/2025

To track analyst ratings and price targets for BigBear.ai Holdings, check out Quiver Quantitative's $BBAI forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Rocket Lab USA (RKLB) have centered on the company's impressive Q3 performance and optimistic Q4 guidance, sparking significant interest among investors. Posts on the platform highlight the company's reported 55% revenue growth and a forecast of over 100% growth for the next quarter, with some users noting a sharp rise in stock price after hours. The chatter reflects growing excitement over Rocket Lab's trajectory as a key player in the space industry.

Additionally, there’s buzz around analyst upgrades, with several posts mentioning raised price targets and buy ratings from major firms, signaling confidence in Rocket Lab’s future. Many are also discussing the potential impact of upcoming projects like the Neutron rocket launch in 2025 and renewed contracts, viewing these as pivotal for the company’s growth. The conversation on X paints a picture of a stock gaining momentum amid broader interest in the space sector.

Note: This discussion summary was generated from an AI condensation of post data.

Rocket Lab USA Insider Trading Activity

Rocket Lab USA insiders have traded $RKLB stock on the open market 58 times in the past 6 months. Of those trades, 0 have been purchases and 58 have been sales.

Here’s a breakdown of recent trading of $RKLB stock by insiders over the last 6 months:

• PETER BECK (President, CEO and Chairman) has made 0 purchases and 8 sales selling 2,500,000 shares for an estimated $127,453,446.
• MATTHEW OCKO has made 0 purchases and 16 sales selling 2,893,097 shares for an estimated $116,894,328.
• ADAM C. SPICE (Chief Financial Officer) has made 0 purchases and 8 sales selling 1,006,286 shares for an estimated $47,018,903.
• FRANK KLEIN (Chief Operations Officer) has made 0 purchases and 11 sales selling 101,639 shares for an estimated $3,832,423.
• ARJUN KAMPANI (SVP General Counsel &) has made 0 purchases and 11 sales selling 85,254 shares for an estimated $3,200,739.
• MERLINE SAINTIL has made 0 purchases and 4 sales selling 12,706 shares for an estimated $398,895.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Rocket Lab USA Hedge Fund Activity

We have seen 7 institutional investors add shares of Rocket Lab USA stock to their portfolio, and 394 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC removed 40,029,546 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,431,856,860
• BLACKROCK, INC. removed 31,598,794 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,130,288,861
• STATE STREET CORP removed 14,344,968 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $513,119,505
• D. E. SHAW & CO., INC. removed 13,636,776 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $487,787,477
• BANK OF AMERICA CORP /DE/ removed 10,660,481 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $381,325,405
• GEODE CAPITAL MANAGEMENT, LLC removed 8,527,477 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $305,027,852
• FMR LLC removed 6,312,268 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $225,789,826

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Rocket Lab USA Government Contracts

We have seen $9,034,002 of award payments to $RKLB over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• VENTURE-CLASS ACQUISITION OF DEDICATED AND RIDESHARE (VADR) UMBRELLA TASK ORDER: $8,486,522
• THE CONTRACTOR SHALL DEVELOP GEN 1 SOLAR SAIL MISSION CONCEPTS THAT WILL ADDRESS THE OBJECTIVES OF A FUTURE...: $546,480
• FOURTH ON-RAMP FOR EGLIN WIDE AGILE ACQUISITION CONTRACT (EWAAC) VEHICLE.: $1,000

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Rocket Lab USA Analyst Ratings

Wall Street analysts have issued reports on $RKLB in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 09/03/2025
• Keybanc issued a "Overweight" rating on 08/08/2025
• Cantor Fitzgerald issued a "Overweight" rating on 08/08/2025
• Roth Capital issued a "Buy" rating on 05/28/2025
• Stifel issued a "Buy" rating on 05/28/2025

To track analyst ratings and price targets for Rocket Lab USA, check out Quiver Quantitative's $RKLB forecast page.

Rocket Lab USA Price Targets

Multiple analysts have issued price targets for $RKLB recently. We have seen 10 analysts offer price targets for $RKLB in the last 6 months, with a median target of $50.0.

Here are some recent targets:

• Ryan Koontz from Needham set a target price of $55.0 on 09/03/2025
• Michael Leshock from Keybanc set a target price of $50.0 on 08/08/2025
• Andres Sheppard from Cantor Fitzgerald set a target price of $54.0 on 08/08/2025
• Erik Rasmussen from Stifel set a target price of $55.0 on 08/05/2025
• Ronald Epstein from B of A Securities set a target price of $50.0 on 07/16/2025
• Jason Gursky from Citigroup set a target price of $50.0 on 07/14/2025
• Anthony Valentini from Goldman Sachs set a target price of $27.0 on 06/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Reddit (RDDT) have been ignited by reports of declining daily active users and reduced reliance on the platform’s data by AI tools like ChatGPT. Many users are expressing concern over a significant drop in stock price, with some pointing to third-party data suggesting weaker user engagement as a key driver. The conversation is intense, as the platform’s role in AI training and data licensing, once seen as a major growth avenue, is now being questioned.

Despite earlier optimism from analyst upgrades and strong quarterly results, the mood on X has shifted as users debate the long-term implications of these setbacks. Some argue that the platform’s premium valuation may be at risk if AI-driven revenue streams falter, while others remain hopeful for a rebound based on Reddit’s past performance. The fluctuating sentiment keeps the dialogue engaging and dynamic, reflecting broader market uncertainties.

Note: This discussion summary was generated from an AI condensation of post data.

Reddit Congressional Stock Trading

Members of Congress have traded $RDDT stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $RDDT stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 04/08, 04/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Reddit Insider Trading Activity

Reddit insiders have traded $RDDT stock on the open market 302 times in the past 6 months. Of those trades, 0 have been purchases and 302 have been sales.

Here’s a breakdown of recent trading of $RDDT stock by insiders over the last 6 months:

• STEVE LADD HUFFMAN (CEO & President) has made 0 purchases and 99 sales selling 493,225 shares for an estimated $64,046,449.
• JENNIFER L. WONG (Chief Operating Officer) has made 0 purchases and 77 sales selling 276,694 shares for an estimated $49,481,096.
• CHRISTOPHER BRIAN SLOWE (Chief Technology Officer) has made 0 purchases and 71 sales selling 140,068 shares for an estimated $23,979,151.
• ANDREW VOLLERO (Chief Financial Officer) has made 0 purchases and 15 sales selling 60,000 shares for an estimated $10,071,737.
• MICHELLE MARIE REYNOLDS (Chief Accounting Officer) has made 0 purchases and 24 sales selling 13,852 shares for an estimated $2,319,357.
• BENJAMIN SEONG LEE (Chief Legal Officer) has made 0 purchases and 16 sales selling 13,280 shares for an estimated $2,090,056.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Reddit Hedge Fund Activity

We have seen 390 institutional investors add shares of Reddit stock to their portfolio, and 278 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BAILLIE GIFFORD & CO added 5,732,328 shares (+764.3%) to their portfolio in Q2 2025, for an estimated $863,116,626
• TIGER GLOBAL MANAGEMENT LLC added 2,899,384 shares (+89.2%) to their portfolio in Q2 2025, for an estimated $436,560,248
• ALLIANCEBERNSTEIN L.P. removed 2,232,345 shares (-39.4%) from their portfolio in Q2 2025, for an estimated $336,124,186
• FMR LLC removed 2,107,677 shares (-15.9%) from their portfolio in Q2 2025, for an estimated $317,352,925
• BLACKROCK, INC. added 2,103,384 shares (+48.7%) to their portfolio in Q2 2025, for an estimated $316,706,528
• D. E. SHAW & CO., INC. removed 1,699,323 shares (-57.3%) from their portfolio in Q2 2025, for an estimated $255,867,064
• SCGE MANAGEMENT, L.P. removed 1,612,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $242,718,840

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Reddit Analyst Ratings

Wall Street analysts have issued reports on $RDDT in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• JMP Securities issued a "Market Outperform" rating on 09/18/2025
• Piper Sandler issued a "Overweight" rating on 09/18/2025
• Oppenheimer issued a "Outperform" rating on 09/16/2025
• Needham issued a "Buy" rating on 09/15/2025
• Jefferies issued a "Buy" rating on 09/10/2025
• Morgan Stanley issued a "Overweight" rating on 08/01/2025
• Raymond James issued a "Strong Buy" rating on 07/28/2025

To track analyst ratings and price targets for Reddit, check out Quiver Quantitative's $RDDT forecast page.

Reddit Price Targets

Multiple analysts have issued price targets for $RDDT recently. We have seen 23 analysts offer price targets for $RDDT in the last 6 months, with a median target of $200.0.

Here are some recent targets:

• Colin Sebastian from Baird set a target price of $240.0 on 09/25/2025
• Thomas Champion from Piper Sandler set a target price of $290.0 on 09/18/2025
• Andrew Boone from JMP Securities set a target price of $300.0 on 09/18/2025
• Jason Helfstein from Oppenheimer set a target price of $300.0 on 09/16/2025
• Laura Martin from Needham set a target price of $300.0 on 09/15/2025
• John Colantuoni from Jefferies set a target price of $300.0 on 09/10/2025
• Brad Erickson from RBC Capital set a target price of $210.0 on 08/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent chatter on X about Iris Energy Limited (IREN) has been notably active, driven by the company's strategic pivot towards AI infrastructure alongside its core Bitcoin mining operations. Many users have expressed enthusiasm over the firm's reported fiscal year 2025 results, highlighting a significant revenue increase and ambitious expansion plans in AI cloud services. The stock's dramatic year-to-date surge has also caught attention, fueling discussions about its long-term potential in high-performance computing.

However, not all sentiments are uniformly positive, as some voices on X have raised concerns about the high capital expenditure required for these expansions and the inherent volatility of the stock. A few have pointed to analyst downgrades and the challenges of balancing mining profitability with AI investments as potential risks. Despite these cautions, the overall tone leans towards optimism as the company continues to position itself at the intersection of cryptocurrency and cutting-edge technology.

Note: This discussion summary was generated from an AI condensation of post data.

Iris Energy Limited Congressional Stock Trading

Members of Congress have traded $IREN stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $IREN stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS purchased up to $50,000 on 07/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Iris Energy Limited Insider Trading Activity

Iris Energy Limited insiders have traded $IREN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $IREN stock by insiders over the last 6 months:

• DANIEL JOHN ROBERTS (Co-Chief Executive Officer) sold 1,000,000 shares for an estimated $33,131,000
• WILLIAM GREGORY ROBERTS (Co-Chief Executive Officer) sold 1,000,000 shares for an estimated $33,131,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Iris Energy Limited Hedge Fund Activity

We have seen 147 institutional investors add shares of Iris Energy Limited stock to their portfolio, and 73 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 8,647,252 shares (+32777.1%) to their portfolio in Q2 2025, for an estimated $125,990,461
• BNP PARIBAS FINANCIAL MARKETS removed 7,298,836 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $106,344,040
• HOOD RIVER CAPITAL MANAGEMENT LLC added 5,094,572 shares (+inf%) to their portfolio in Q2 2025, for an estimated $74,227,914
• JANE STREET GROUP, LLC added 5,041,519 shares (+152.3%) to their portfolio in Q2 2025, for an estimated $73,454,931
• WALLEYE TRADING LLC removed 3,606,413 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $52,545,437
• D. E. SHAW & CO., INC. removed 3,511,320 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $51,159,932
• VALUE ALIGNED RESEARCH ADVISORS, LLC added 3,266,148 shares (+inf%) to their portfolio in Q2 2025, for an estimated $47,587,776

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Iris Energy Limited Analyst Ratings

Wall Street analysts have issued reports on $IREN in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Underweight" rating on 09/26/2025
• Arete Research issued a "Buy" rating on 09/24/2025
• Roth Capital issued a "Buy" rating on 09/23/2025
• BTIG issued a "Buy" rating on 09/09/2025
• Canaccord Genuity issued a "Buy" rating on 08/29/2025
• Macquarie issued a "Outperform" rating on 08/29/2025
• HC Wainwright & Co. issued a "Buy" rating on 08/29/2025

To track analyst ratings and price targets for Iris Energy Limited, check out Quiver Quantitative's $IREN forecast page.

Iris Energy Limited Price Targets

Multiple analysts have issued price targets for $IREN recently. We have seen 9 analysts offer price targets for $IREN in the last 6 months, with a median target of $41.0.

Here are some recent targets:

• Paul Golding from Macquarie set a target price of $55.0 on 09/29/2025
• Reginald Smith from JP Morgan set a target price of $24.0 on 09/26/2025
• An analyst from Arete Research set a target price of $78.0 on 09/24/2025
• Darren Aftahi from Roth Capital set a target price of $82.0 on 09/23/2025
• Joseph Vafi from Canaccord Genuity set a target price of $42.0 on 09/16/2025
• Gregory Lewis from BTIG set a target price of $32.0 on 09/09/2025
• Lucas Pipes from B. Riley Securities set a target price of $29.0 on 08/29/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about NVIDIA (NVDA) have been buzzing with reactions to reports of potential changes in U.S. export policies for AI chips, as well as the company’s stock performance following analyst upgrades. Many users are focusing on the implications of possible export caps to certain countries, with some expressing concern over how this could impact NVIDIA’s global revenue streams. The conversation also highlights a recent uptick in stock price, attributed by some to renewed optimism in the AI sector.

Additionally, there’s a notable divide among participants regarding NVIDIA’s long-term growth prospects amidst competitive pressures from alternatives in the AI chip market. Posts on X reflect a mix of bullish sentiment driven by the company’s dominance in datacenter demand and partnerships, while others caution about potential headwinds from regulatory challenges. The dynamic nature of these discussions keeps the spotlight on NVIDIA as a key player in the tech landscape.

Note: This discussion summary was generated from an AI condensation of post data.

NVIDIA Congressional Stock Trading

Members of Congress have traded $NVDA stock 74 times in the past 6 months. Of those trades, 65 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 41 times. They made 41 purchases worth up to $12,015,000 on 09/03, 08/22, 08/20, 08/15, 08/13, 08/06, 08/01, 07/29, 07/17, 07/16, 07/14, 07/10, 06/30, 06/26, 06/25, 06/09, 06/05, 06/03 and 0 sales.
• SENATOR JOHN BOOZMAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/22, 05/13 and 0 sales.
• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
• SENATOR SHELDON WHITEHOUSE has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 07/07, 04/14.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/24 and 1 sale worth up to $15,000 on 04/09.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 3 purchases worth up to $45,000 on 06/17, 06/11, 06/09 and 1 sale worth up to $15,000 on 06/10.
• REPRESENTATIVE VAL T. HOYLE has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/09, 06/06 and 0 sales.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 6 times. They made 6 purchases worth up to $90,000 on 05/29, 05/23, 05/16, 05/13, 05/09, 04/11 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/14, 05/05, 04/09 and 0 sales.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $250,000 on 05/08 and 2 sales worth up to $1,100,000 on 05/12, 04/07.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $50,000 on 04/21.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 3 purchases worth up to $45,000 on 04/16, 04/07 and 0 sales.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE TERRI A. SEWELL purchased up to $15,000 on 04/10.
• REPRESENTATIVE JULIE JOHNSON sold up to $50,000 on 04/07.
• REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

NVIDIA Insider Trading Activity

NVIDIA insiders have traded $NVDA stock on the open market 384 times in the past 6 months. Of those trades, 0 have been purchases and 384 have been sales.

Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:

• JEN HSUN HUANG (President and CEO) has made 0 purchases and 259 sales selling 4,500,000 shares for an estimated $769,669,706.
• MARK A STEVENS has made 0 purchases and 8 sales selling 2,875,730 shares for an estimated $438,775,005.
• TENCH COXE sold 1,000,000 shares for an estimated $142,804,600
• A BROOKE SEAWELL has made 0 purchases and 53 sales selling 770,522 shares for an estimated $119,998,758.
• HARVEY C JONES sold 250,000 shares for an estimated $44,053,700
• COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 48 sales selling 196,290 shares for an estimated $32,815,868.
• AJAY K PURI (EVP, Worldwide Field Ops) has made 0 purchases and 5 sales selling 168,195 shares for an estimated $25,673,039.
• DAWN E HUDSON has made 0 purchases and 2 sales selling 90,000 shares for an estimated $15,381,064.
• PERSIS DRELL sold 40,000 shares for an estimated $7,106,120
• ROBERT K BURGESS sold 50,000 shares for an estimated $6,740,819
• STEPHEN C NEAL sold 28,000 shares for an estimated $4,972,343
• DONALD F JR ROBERTSON (Principal Accounting Officer) has made 0 purchases and 3 sales selling 8,000 shares for an estimated $1,263,767.
• JOHN DABIRI sold 660 shares for an estimated $91,608

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NVIDIA Hedge Fund Activity

We have seen 2,906 institutional investors add shares of NVIDIA stock to their portfolio, and 2,012 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 382,231,120 shares (+267959.7%) to their portfolio in Q2 2025, for an estimated $60,388,694,648
• GAMMA INVESTING LLC removed 48,327,113 shares (-99.0%) from their portfolio in Q2 2025, for an estimated $7,635,200,582
• CAPITAL RESEARCH GLOBAL INVESTORS added 46,228,880 shares (+48.0%) to their portfolio in Q2 2025, for an estimated $7,303,700,751
• JPMORGAN CHASE & CO added 41,486,164 shares (+9.9%) to their portfolio in Q2 2025, for an estimated $6,554,399,050
• VANGUARD GROUP INC added 39,465,689 shares (+1.8%) to their portfolio in Q2 2025, for an estimated $6,235,184,205
• PRICE T ROWE ASSOCIATES INC /MD/ added 31,338,927 shares (+8.4%) to their portfolio in Q2 2025, for an estimated $4,951,237,076
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 30,727,360 shares (+14.9%) to their portfolio in Q2 2025, for an estimated $4,854,615,606

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NVIDIA Analyst Ratings

Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 27 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 09/30/2025
• Keybanc issued a "Overweight" rating on 09/30/2025
• Jefferies issued a "Buy" rating on 09/29/2025
• Barclays issued a "Overweight" rating on 09/25/2025
• DA Davidson issued a "Buy" rating on 09/23/2025
• Rosenblatt issued a "Buy" rating on 09/23/2025
• Cantor Fitzgerald issued a "Overweight" rating on 08/28/2025

To track analyst ratings and price targets for NVIDIA, check out Quiver Quantitative's $NVDA forecast page.

NVIDIA Price Targets

Multiple analysts have issued price targets for $NVDA recently. We have seen 32 analysts offer price targets for $NVDA in the last 6 months, with a median target of $217.5.

Here are some recent targets:

• John Vinh from Keybanc set a target price of $250.0 on 09/30/2025
• Atif Malik from Citigroup set a target price of $210.0 on 09/30/2025
• An analyst from Jefferies set a target price of $220.0 on 09/29/2025
• Tom O'Malley from Barclays set a target price of $240.0 on 09/25/2025
• Gil Luria from DA Davidson set a target price of $210.0 on 09/23/2025
• Kevin Cassidy from Rosenblatt set a target price of $215.0 on 09/23/2025
• Mark Lipacis from Evercore ISI Group set a target price of $225.0 on 09/23/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about MicroStrategy (MSTR) have been buzzing with speculation over the company's aggressive Bitcoin acquisition strategy and its impact on stock volatility. Many users are captivated by the firm's latest purchase of additional Bitcoin, with some expressing optimism that this could drive the stock price to new heights by the end of 2025. The conversation often ties MSTR’s performance to broader cryptocurrency market trends, keeping the dialogue dynamic and heated.

However, not all sentiments are bullish, as a portion of the X community has raised concerns over valuation premiums and the risks tied to the company's heavy reliance on Bitcoin holdings. Some have pointed to recent analyst reports suggesting caution due to potential overexposure, while others predict significant upside if key technical levels hold. This polarized debate continues to fuel intense interest in MSTR’s next moves.

Note: This discussion summary was generated from an AI condensation of post data.

MicroStrategy Congressional Stock Trading

Members of Congress have traded $MSTR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MSTR stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MicroStrategy Insider Trading Activity

MicroStrategy insiders have traded $MSTR stock on the open market 132 times in the past 6 months. Of those trades, 17 have been purchases and 115 have been sales.

Here’s a breakdown of recent trading of $MSTR stock by insiders over the last 6 months:

• WEI-MING SHAO (EVP & General Counsel) has made 3 purchases buying 18,527 shares for an estimated $1,736,245 and 51 sales selling 115,101 shares for an estimated $45,326,921.
• PETER L JR BRIGER purchased 220,000 shares for an estimated $19,800,000
• JEANINE MONTGOMERY (VP & CAO) has made 1 purchase buying 5,000 shares for an estimated $450,000 and 9 sales selling 44,090 shares for an estimated $18,963,468.
• ANDREW KANG (EVP & CFO) has made 2 purchases buying 5,050 shares for an estimated $443,250 and 16 sales selling 32,515 shares for an estimated $12,836,556.
• JARROD M PATTEN has made 3 purchases buying 20,555 shares for an estimated $1,938,730 and 28 sales selling 27,950 shares for an estimated $10,723,302.
• CARL J RICKERTSEN has made 0 purchases and 3 sales selling 27,370 shares for an estimated $10,199,235.
• PHONG LE (President & CEO) has made 5 purchases buying 10,119 shares for an estimated $888,808 and 8 sales selling 5,295 shares for an estimated $1,983,193.
• GREGG WINIARSKI purchased 10,000 shares for an estimated $976,520
• JANE A DIETZE purchased 1,500 shares for an estimated $135,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MicroStrategy Hedge Fund Activity

We have seen 725 institutional investors add shares of MicroStrategy stock to their portfolio, and 339 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CLEAR STREET LLC added 5,971,971 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,414,049,837
• CLEAR STREET DERIVATIVES LLC removed 5,283,815 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,135,876,537
• VANGUARD GROUP INC removed 2,047,255 shares (-9.9%) from their portfolio in Q2 2025, for an estimated $827,561,888
• JPMORGAN CHASE & CO added 2,024,218 shares (+180.1%) to their portfolio in Q2 2025, for an estimated $818,249,642
• CITADEL ADVISORS LLC removed 1,547,066 shares (-99.2%) from their portfolio in Q2 2025, for an estimated $625,370,489
• MORGAN STANLEY added 1,511,317 shares (+19.7%) to their portfolio in Q2 2025, for an estimated $610,919,670
• FMR LLC added 1,499,669 shares (+266.5%) to their portfolio in Q2 2025, for an estimated $606,211,199

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MicroStrategy Government Contracts

We have seen $29,200 of award payments to $MSTR over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• MICROSTRATEGY TECHNICAL SUPPORT STANDARD RENEWAL - FY25 HHS PROGRAM PERFORMANCE TRACKING SYSTEM: $29,200

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

MicroStrategy Analyst Ratings

Wall Street analysts have issued reports on $MSTR in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• TD Cowen issued a "Buy" rating on 09/16/2025
• Canaccord Genuity issued a "Buy" rating on 08/26/2025
• Mizuho issued a "Outperform" rating on 08/11/2025
• Benchmark issued a "Buy" rating on 08/01/2025
• BTIG issued a "Buy" rating on 08/01/2025
• Cantor Fitzgerald issued a "Overweight" rating on 07/28/2025
• Barclays issued a "Overweight" rating on 05/05/2025

To track analyst ratings and price targets for MicroStrategy, check out Quiver Quantitative's $MSTR forecast page.

MicroStrategy Price Targets

Multiple analysts have issued price targets for $MSTR recently. We have seen 9 analysts offer price targets for $MSTR in the last 6 months, with a median target of $586.0.

Here are some recent targets:

• Cerena Chen from Wells Fargo set a target price of $54.0 on 09/30/2025
• Lance Vitanza from TD Cowen set a target price of $620.0 on 09/16/2025
• Joseph Vafi from Canaccord Genuity set a target price of $464.0 on 08/26/2025
• Dan Dolev from Mizuho set a target price of $586.0 on 08/11/2025
• Andrew Harte from BTIG set a target price of $700.0 on 08/01/2025
• Mark Palmer from Benchmark set a target price of $705.0 on 08/01/2025
• Brett Knoblauch from Cantor Fitzgerald set a target price of $697.0 on 08/01/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Ameresco, Inc. (AMRC) have centered on a significant upgrade by a prominent financial group, which shifted its rating from hold to buy and raised the price target substantially. Many users are highlighting this development as a sign of reduced execution risks and potential for strong growth in EBITDA, driven by data center projects and renewed momentum in the company’s core business. The buzz reflects a renewed confidence in the stock’s trajectory following this positive analyst sentiment.

Additionally, chatter on X has pointed to Ameresco’s strategic positioning in the energy sector, with some expressing optimism about its role in addressing outdated U.S. power grid infrastructure. Posts also mention recent partnerships and projects as catalysts for the stock’s upward movement in recent weeks. This wave of attention underscores a growing interest in the company’s long-term prospects amidst evolving energy demands.

Note: This discussion summary was generated from an AI condensation of post data.

Ameresco, Inc. Insider Trading Activity

Ameresco, Inc. insiders have traded $AMRC stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $AMRC stock by insiders over the last 6 months:

• MARK CHIPLOCK (EVP, CFO & CAO) sold 269 shares for an estimated $7,532
• DAVID J CORRSIN (EVP and General Counsel) has made 0 purchases and 2 sales selling 38 shares for an estimated $1,045.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Ameresco, Inc. Hedge Fund Activity

We have seen 91 institutional investors add shares of Ameresco, Inc. stock to their portfolio, and 88 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FIRST TRUST ADVISORS LP added 1,683,326 shares (+1832.5%) to their portfolio in Q2 2025, for an estimated $25,569,721
• WELLINGTON MANAGEMENT GROUP LLP added 653,780 shares (+59.4%) to their portfolio in Q2 2025, for an estimated $9,930,918
• ARDSLEY ADVISORY PARTNERS LP removed 400,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,076,000
• STATE STREET CORP added 387,571 shares (+35.8%) to their portfolio in Q2 2025, for an estimated $5,887,203
• CENTERBOOK PARTNERS LP removed 318,675 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,840,673
• MARSHALL WACE, LLP removed 279,734 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,249,159
• ROYCE & ASSOCIATES LP added 243,904 shares (+304.9%) to their portfolio in Q2 2025, for an estimated $3,704,901

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Ameresco, Inc. Government Contracts

We have seen $571,475,860 of award payments to $AMRC over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• ENERGY SAVINGS PERFORMANCE CONTRACT, NATIONAL DEEP ENERGY RETROFIT PROGRAM ROUND 7, REGION 5 FOR IMPLEMENTA...: $217,262,240
• ENERGY SAVINGS PERFORMANCE CONTRACT, NATIONAL DEEP ENERGY RETROFIT PROGRAM ROUND 6, REGION 8 FOR IMPLEMENTA...: $140,229,695
• ENERGY SAVINGS PERFROMANCE CONTRACT, NATIONAL DEEP ENERGY RETROFIT PROGAM ROUND 7, R11 PROJECT 2 FOR IMPLEM...: $39,939,634
• IGF::OT::IGF ENERGY SAVINGS PERFORMANCE CONTRACT. INVOLVES THE INSTALLATION AND LONG TERM MEASUREMENT&VERI...: $39,052,544
• VETERANS INTEGRATED SERVICE NETWORK (VISN) 7 ENERGY SAVINGS PERFORMANCE CONTRACT (ESPC): $19,581,666

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Ameresco, Inc. Analyst Ratings

Wall Street analysts have issued reports on $AMRC in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 09/25/2025
• B. Riley Securities issued a "Buy" rating on 09/10/2025
• Baird issued a "Outperform" rating on 09/02/2025
• UBS issued a "Sell" rating on 06/03/2025
• Stifel issued a "Buy" rating on 05/12/2025
• Piper Sandler issued a "Overweight" rating on 05/06/2025
• Canaccord Genuity issued a "Buy" rating on 05/06/2025

To track analyst ratings and price targets for Ameresco, Inc., check out Quiver Quantitative's $AMRC forecast page.

Ameresco, Inc. Price Targets

Multiple analysts have issued price targets for $AMRC recently. We have seen 7 analysts offer price targets for $AMRC in the last 6 months, with a median target of $29.0.

Here are some recent targets:

• Julien Dumoulin-Smith from Jefferies set a target price of $39.0 on 09/25/2025
• Christopher Souther from B. Riley Securities set a target price of $32.0 on 09/10/2025
• Ben Kallo from Baird set a target price of $35.0 on 09/02/2025
• Jon Windham from UBS set a target price of $23.0 on 08/18/2025
• Stephen Gengaro from Stifel set a target price of $17.0 on 05/12/2025
• Kashy Harrison from Piper Sandler set a target price of $21.0 on 05/06/2025
• George Gianarikas from Canaccord Genuity set a target price of $29.0 on 05/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about MercadoLibre (MELI) have been buzzing with reactions to the company’s latest stock performance, particularly following a notable 7% drop in share price during a single trading session. Many users are pointing to broader macroeconomic concerns in Latin America as a key driver behind this slide, with some expressing worries about geopolitical risks impacting the region’s e-commerce leader. Despite the dip, there’s a sense of intrigue as others highlight the company’s strong year-to-date gains of over 46%, suggesting resilience amid volatility.

Additionally, posts on X have focused on MercadoLibre’s dual strengths in e-commerce and fintech, with several noting impressive growth metrics like revenue increases and expanding user bases across both sectors. However, concerns about margin pressures from heavy investments in logistics and promotional spending are also circulating, creating a dynamic debate about the sustainability of its growth trajectory. The conversation remains lively as investors weigh the balance between short-term challenges and long-term potential in this Latin American juggernaut.

Note: This discussion summary was generated from an AI condensation of post data.

MercadoLibre Congressional Stock Trading

Members of Congress have traded $MELI stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MELI stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $80,000 on 08/28, 05/14, 05/05 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MercadoLibre Hedge Fund Activity

We have seen 746 institutional investors add shares of MercadoLibre stock to their portfolio, and 589 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• LAVACA CAPITAL LLC added 1,065,530 shares (+140201.3%) to their portfolio in Q2 2025, for an estimated $2,784,901,173
• CAPITAL RESEARCH GLOBAL INVESTORS removed 467,897 shares (-21.0%) from their portfolio in Q2 2025, for an estimated $1,222,909,636
• JPMORGAN CHASE & CO added 432,231 shares (+27.7%) to their portfolio in Q2 2025, for an estimated $1,129,691,908
• PITCAIRN CO added 319,257 shares (+64496.4%) to their portfolio in Q2 2025, for an estimated $834,419,672
• BAILLIE GIFFORD & CO removed 278,805 shares (-7.4%) from their portfolio in Q2 2025, for an estimated $728,693,112
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 192,071 shares (+304.7%) to their portfolio in Q2 2025, for an estimated $502,002,527
• ASSENAGON ASSET MANAGEMENT S.A. removed 143,577 shares (-52.2%) from their portfolio in Q2 2025, for an estimated $375,257,154

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MercadoLibre Analyst Ratings

Wall Street analysts have issued reports on $MELI in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Cantor Fitzgerald issued a "Overweight" rating on 09/24/2025
• Citigroup issued a "Buy" rating on 08/18/2025
• Scotiabank issued a "Sector Outperform" rating on 07/28/2025
• Barclays issued a "Overweight" rating on 07/23/2025
• Susquehanna issued a "Positive" rating on 06/26/2025
• Goldman Sachs issued a "Buy" rating on 05/14/2025
• Benchmark issued a "Buy" rating on 04/15/2025

To track analyst ratings and price targets for MercadoLibre, check out Quiver Quantitative's $MELI forecast page.

MercadoLibre Price Targets

Multiple analysts have issued price targets for $MELI recently. We have seen 13 analysts offer price targets for $MELI in the last 6 months, with a median target of $2850.0.

Here are some recent targets:

• Deepak Mathivanan from Cantor Fitzgerald set a target price of $2900.0 on 09/24/2025
• Joao Pedro Soares from Citigroup set a target price of $2850.0 on 08/18/2025
• Marcelo Santos from JP Morgan set a target price of $2700.0 on 08/07/2025
• John Colantuoni from Jefferies set a target price of $2800.0 on 08/05/2025
• Scott Devitt from Wedbush set a target price of $2700.0 on 08/05/2025
• Josh Beck from Raymond James set a target price of $2750.0 on 08/05/2025
• Fawne Jiang from Benchmark set a target price of $2875.0 on 08/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about ASML Holding NV have ignited around the company's latest guidance for 2025, which projected a significant downturn in growth expectations. Many users expressed concern over a sharp decline in the stock price following the announcement, with some pointing to broader implications for the semiconductor industry amid a sluggish chip market recovery. The conversation reflects a palpable tension as global trade restrictions and geopolitical risks continue to loom large.

Despite the pessimism, there are pockets of optimism among users who highlight ASML's critical role in enabling AI and tech advancements, with some arguing the recent dip could represent a strategic entry point. Others remain cautious, noting the high valuation and uncertainties tied to export controls impacting future performance. This dynamic debate keeps the ticker at the forefront of industry watchers’ attention.

Note: This discussion summary was generated from an AI condensation of post data.

ASML Holding NV Congressional Stock Trading

Members of Congress have traded $ASML stock 11 times in the past 6 months. Of those trades, 5 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $ASML stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/11, 04/09 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/17, 06/09 and 1 sale worth up to $15,000 on 07/22.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 06/27.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 05/22 and 1 sale worth up to $15,000 on 04/17.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ASML Holding NV Hedge Fund Activity

We have seen 892 institutional investors add shares of ASML Holding NV stock to their portfolio, and 656 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• INFINITUM ASSET MANAGEMENT, LLC removed 6,616,300 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $5,302,236,657
• GAMMA INVESTING LLC removed 1,398,172 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $1,120,481,059
• EAGLE CAPITAL MANAGEMENT LLC added 1,225,871 shares (+inf%) to their portfolio in Q2 2025, for an estimated $982,400,760
• FMR LLC removed 963,980 shares (-38.4%) from their portfolio in Q2 2025, for an estimated $772,523,932
• JANUS HENDERSON GROUP PLC removed 701,019 shares (-87.9%) from their portfolio in Q2 2025, for an estimated $561,789,616
• AMUNDI removed 632,346 shares (-98.4%) from their portfolio in Q2 2025, for an estimated $506,755,760
• VICTORY CAPITAL MANAGEMENT INC added 597,442 shares (+1491.4%) to their portfolio in Q2 2025, for an estimated $478,784,044

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ASML Holding NV Analyst Ratings

Wall Street analysts have issued reports on $ASML in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 09/05/2025
• Wells Fargo issued a "Overweight" rating on 04/17/2025
• Susquehanna issued a "Positive" rating on 04/17/2025
• Raymond James issued a "Strong Buy" rating on 04/16/2025

To track analyst ratings and price targets for ASML Holding NV, check out Quiver Quantitative's $ASML forecast page.

ASML Holding NV Price Targets

Multiple analysts have issued price targets for $ASML recently. We have seen 3 analysts offer price targets for $ASML in the last 6 months, with a median target of $890.0.

Here are some recent targets:

• Joseph Quatrochi from Wells Fargo set a target price of $890.0 on 07/08/2025
• Mehdi Hosseini from Susquehanna set a target price of $965.0 on 04/17/2025
• Srini Pajjuri from Raymond James set a target price of $850.0 on 04/16/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Advanced Micro Devices (AMD) have centered around the company's strategic positioning in the AI and semiconductor markets. Many users are highlighting AMD's advancements with its MI series chips, with some expressing optimism about potential market share gains against competitors. There's also buzz about partnerships and performance benchmarks that could signal strong growth as we move through 2025.

Additionally, posts on X reflect excitement over AMD's revenue forecasts and product pricing strategies, particularly with chips like the MI350, which some believe could challenge industry leaders. Conversations often mention the stock's potential for significant rallies, driven by AI demand and data center growth. However, a few voices caution about macroeconomic risks and volatility in the sector that could impact future performance.

Note: This discussion summary was generated from an AI condensation of post data.

Advanced Micro Devices Congressional Stock Trading

Members of Congress have traded $AMD stock 16 times in the past 6 months. Of those trades, 13 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $AMD stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 08/18.
• REPRESENTATIVE CLEO FIELDS has traded it 3 times. They made 3 purchases worth up to $150,000 on 08/15, 08/01, 07/30 and 0 sales.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 08/07.
• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $50,000 on 05/15 and 1 sale worth up to $50,000 on 04/08.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 4 times. They made 4 purchases worth up to $60,000 on 05/14, 05/05, 04/09, 04/08 and 0 sales.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 05/08 and 2 sales worth up to $200,000 on 05/12, 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Advanced Micro Devices Insider Trading Activity

Advanced Micro Devices insiders have traded $AMD stock on the open market 29 times in the past 6 months. Of those trades, 1 have been purchases and 28 have been sales.

Here’s a breakdown of recent trading of $AMD stock by insiders over the last 6 months:

• LISA T SU (Chair, President & CEO) has made 0 purchases and 4 sales selling 225,000 shares for an estimated $36,893,351.
• MARK D PAPERMASTER (Chief Technology Officer & EVP) has made 0 purchases and 16 sales selling 104,098 shares for an estimated $14,197,903.
• FORREST EUGENE NORROD (EVP & GM DESG) has made 0 purchases and 6 sales selling 19,450 shares for an estimated $3,139,293.
• PAUL DARREN GRASBY (EVP & CSO) sold 10,000 shares for an estimated $1,732,100
• PHILIP GUIDO (EVP & Chief Commercial Officer) purchased 8,800 shares for an estimated $999,328
• AVA HAHN (SVP, GC & Corporate Secretary) sold 143 shares for an estimated $22,608

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Advanced Micro Devices Hedge Fund Activity

We have seen 1,335 institutional investors add shares of Advanced Micro Devices stock to their portfolio, and 1,046 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ added 13,526,953 shares (+106.2%) to their portfolio in Q2 2025, for an estimated $1,919,474,630
• VICTORY CAPITAL MANAGEMENT INC added 7,886,163 shares (+651.5%) to their portfolio in Q2 2025, for an estimated $1,119,046,529
• INFINITUM ASSET MANAGEMENT, LLC removed 7,121,800 shares (-99.0%) from their portfolio in Q2 2025, for an estimated $1,010,583,420
• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 6,870,480 shares (+inf%) to their portfolio in Q2 2025, for an estimated $974,921,112
• AMUNDI removed 6,355,648 shares (-35.6%) from their portfolio in Q2 2025, for an estimated $901,866,451
• FMR LLC added 5,312,149 shares (+57.5%) to their portfolio in Q2 2025, for an estimated $753,793,943
• BNP PARIBAS FINANCIAL MARKETS removed 3,993,194 shares (-36.5%) from their portfolio in Q2 2025, for an estimated $566,634,228

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Advanced Micro Devices Analyst Ratings

Wall Street analysts have issued reports on $AMD in the last several months. We have seen 20 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HSBC issued a "Buy" rating on 09/09/2025
• Truist Securities issued a "Buy" rating on 08/26/2025
• Mizuho issued a "Outperform" rating on 08/14/2025
• Piper Sandler issued a "Overweight" rating on 08/06/2025
• Wedbush issued a "Outperform" rating on 08/06/2025
• Barclays issued a "Overweight" rating on 08/06/2025
• Susquehanna issued a "Positive" rating on 07/30/2025

To track analyst ratings and price targets for Advanced Micro Devices, check out Quiver Quantitative's $AMD forecast page.

Advanced Micro Devices Price Targets

Multiple analysts have issued price targets for $AMD recently. We have seen 30 analysts offer price targets for $AMD in the last 6 months, with a median target of $186.5.

Here are some recent targets:

• Frank Lee from HSBC set a target price of $185.0 on 09/09/2025
• William Stein from Truist Securities set a target price of $213.0 on 08/26/2025
• Vijay Rakesh from Mizuho set a target price of $205.0 on 08/14/2025
• Harlan Sur from JP Morgan set a target price of $180.0 on 08/06/2025
• Cody Acree from Benchmark set a target price of $210.0 on 08/06/2025
• Tom O'Malley from Barclays set a target price of $200.0 on 08/06/2025
• Mark Lipacis from Evercore ISI Group set a target price of $188.0 on 08/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about IonQ, Inc. (IONQ) have been buzzing with reactions to the company’s latest technological advancements in quantum computing. Posts on the platform highlight a breakthrough in photon frequency conversion, which some users suggest could pave the way for a quantum internet. The excitement is tempered by concerns over the stock’s high market cap relative to the company’s current operational status, with debates on whether the hype matches the reality.

Additionally, there’s a split in opinions regarding IonQ’s long-term potential versus short-term challenges. Some discussions point to the company’s modular approach and strategic moves as a strong foundation for future growth, while others express skepticism about system reliability and competition in the quantum computing space. This dynamic conversation reflects the high stakes and uncertainty surrounding this cutting-edge sector.

Note: This discussion summary was generated from an AI condensation of post data.

IonQ, Inc. Insider Trading Activity

IonQ, Inc. insiders have traded $IONQ stock on the open market 29 times in the past 6 months. Of those trades, 0 have been purchases and 29 have been sales.

Here’s a breakdown of recent trading of $IONQ stock by insiders over the last 6 months:

• PETER HUME CHAPMAN (Executive Chair) has made 0 purchases and 4 sales selling 6,001,209 shares for an estimated $231,229,952.
• MASI NICCOLO DE (President and CEO) has made 0 purchases and 3 sales selling 2,622,900 shares for an estimated $105,900,928.
• THOMAS G. KRAMER (Chief Financial Officer) has made 0 purchases and 7 sales selling 471,208 shares for an estimated $19,460,492.
• RIMA ALAMEDDINE (Chief Revenue Officer) has made 0 purchases and 4 sales selling 149,952 shares for an estimated $6,302,733.
• INDER M SINGH has made 0 purchases and 3 sales selling 130,961 shares for an estimated $5,291,564.
• KATHRYN K. CHOU has made 0 purchases and 3 sales selling 37,485 shares for an estimated $1,563,531.
• ROBERT T. CARDILLO has made 0 purchases and 2 sales selling 18,831 shares for an estimated $847,769.
• WENDY THOMAS sold 16,696 shares for an estimated $658,296
• PAUL T DACIER (Chief Administrative Officer) sold 4,175 shares for an estimated $185,376
• GABRIELLE B TOLEDANO sold 792 shares for an estimated $32,868

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

IonQ, Inc. Hedge Fund Activity

We have seen 327 institutional investors add shares of IonQ, Inc. stock to their portfolio, and 129 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MORGAN STANLEY added 15,086,026 shares (+290.2%) to their portfolio in Q2 2025, for an estimated $648,246,537
• D. E. SHAW & CO., INC. removed 3,900,091 shares (-49.1%) from their portfolio in Q2 2025, for an estimated $167,586,910
• VANGUARD GROUP INC added 3,269,482 shares (+15.2%) to their portfolio in Q2 2025, for an estimated $140,489,641
• NORGES BANK added 2,524,895 shares (+1729.7%) to their portfolio in Q2 2025, for an estimated $108,494,738
• CERBERUS CAPITAL MANAGEMENT, L.P. added 2,433,560 shares (+inf%) to their portfolio in Q2 2025, for an estimated $104,570,073
• JPMORGAN CHASE & CO added 2,310,058 shares (+634.1%) to their portfolio in Q2 2025, for an estimated $99,263,192
• BLACKROCK, INC. added 2,227,646 shares (+13.9%) to their portfolio in Q2 2025, for an estimated $95,721,948

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

IonQ, Inc. Analyst Ratings

Wall Street analysts have issued reports on $IONQ in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 09/17/2025
• Benchmark issued a "Buy" rating on 09/16/2025
• Rosenblatt issued a "Buy" rating on 09/15/2025
• Cantor Fitzgerald issued a "Overweight" rating on 09/15/2025
• B. Riley Securities issued a "Buy" rating on 09/15/2025
• DA Davidson issued a "Buy" rating on 04/14/2025

To track analyst ratings and price targets for IonQ, Inc., check out Quiver Quantitative's $IONQ forecast page.

IonQ, Inc. Price Targets

Multiple analysts have issued price targets for $IONQ recently. We have seen 8 analysts offer price targets for $IONQ in the last 6 months, with a median target of $65.0.

Here are some recent targets:

• Craig Ellis from B. Riley Securities set a target price of $100.0 on 09/22/2025
• N. Quinn Bolton from Needham set a target price of $80.0 on 09/17/2025
• David Williams from Benchmark set a target price of $75.0 on 09/16/2025
• Kevin Garrigan from Rosenblatt set a target price of $70.0 on 09/15/2025
• Troy Jensen from Cantor Fitzgerald set a target price of $60.0 on 09/15/2025
• Scott Fessler from Morgan Stanley set a target price of $30.0 on 05/08/2025
• Alex Platt from DA Davidson set a target price of $35.0 on 04/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Intel Corporation (INTC) have been buzzing with activity, largely driven by reports of potential investments and strategic partnerships. Many users are focusing on the stock's significant rally, with some noting a surge of over 20% in a single week amid news of talks with major tech players and substantial financial backing. The conversation reflects a renewed interest in Intel's efforts to reposition itself in the competitive semiconductor market.

While optimism permeates much of the dialogue, there are also voices of caution circulating on the platform. Some participants have pointed out that the recent price spikes seem fueled more by headlines than by fundamental improvements, highlighting ongoing concerns about revenue declines and operational challenges. This mixed feedback paints a complex picture of Intel's current standing among investors and tech enthusiasts on social media.

Note: This discussion summary was generated from an AI condensation of post data.

Intel Corporation Congressional Stock Trading

Members of Congress have traded $INTC stock 12 times in the past 6 months. Of those trades, 6 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $INTC stock by members of Congress over the last 6 months:

• REPRESENTATIVE TIM MOORE has traded it 5 times. They made 4 purchases worth up to $200,000 on 08/11, 08/08, 08/01, 07/29 and 1 sale worth up to $250,000 on 08/13.
• REPRESENTATIVE CLEO FIELDS sold up to $15,000 on 06/30.
• REPRESENTATIVE J. FRENCH HILL sold up to $50,000 on 06/23.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 06/11, 06/06.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/07.
• REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Intel Corporation Hedge Fund Activity

We have seen 792 institutional investors add shares of Intel Corporation stock to their portfolio, and 1,115 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 15,412,728 shares (+inf%) to their portfolio in Q2 2025, for an estimated $345,245,107
• MORGAN STANLEY added 11,494,467 shares (+22.2%) to their portfolio in Q2 2025, for an estimated $257,476,060
• JPMORGAN CHASE & CO removed 11,226,429 shares (-21.9%) from their portfolio in Q2 2025, for an estimated $251,472,009
• ASSENAGON ASSET MANAGEMENT S.A. added 10,523,590 shares (+86.4%) to their portfolio in Q2 2025, for an estimated $235,728,415
• AQR CAPITAL MANAGEMENT LLC added 10,514,007 shares (+210.9%) to their portfolio in Q2 2025, for an estimated $235,513,756
• BARCLAYS PLC added 9,222,590 shares (+31.2%) to their portfolio in Q2 2025, for an estimated $206,586,016
• VANGUARD GROUP INC added 8,513,298 shares (+2.3%) to their portfolio in Q2 2025, for an estimated $190,697,875

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Intel Corporation Analyst Ratings

Wall Street analysts have issued reports on $INTC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Benchmark issued a "Buy" rating on 09/19/2025
• JP Morgan issued a "Underweight" rating on 07/25/2025
• Rosenblatt issued a "Sell" rating on 07/25/2025

To track analyst ratings and price targets for Intel Corporation, check out Quiver Quantitative's $INTC forecast page.

Intel Corporation Price Targets

Multiple analysts have issued price targets for $INTC recently. We have seen 16 analysts offer price targets for $INTC in the last 6 months, with a median target of $23.0.

Here are some recent targets:

• Ross Seymore from Deutsche Bank set a target price of $30.0 on 09/29/2025
• Timothy Arcuri from UBS set a target price of $35.0 on 09/19/2025
• Tom O'Malley from Barclays set a target price of $25.0 on 09/19/2025
• Christopher Danely from Citigroup set a target price of $29.0 on 09/19/2025
• Cody Acree from Benchmark set a target price of $43.0 on 09/19/2025
• Harlan Sur from JP Morgan set a target price of $21.0 on 07/25/2025
• Kevin Cassidy from Rosenblatt set a target price of $14.0 on 07/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent chatter on X about Opendoor Technologies (OPEN) has been buzzing with excitement, largely fueled by a dramatic stock price surge of over 170% in 2025 and significant leadership changes. Many users are captivated by the high trading volumes and potential short squeeze dynamics, drawing comparisons to past meme-stock frenzies. Discussions also highlight upcoming catalysts, such as a new CEO appointment and the return of co-founders, which have added fuel to the speculative fire.

However, not all sentiments are uniformly positive, as some voices on X express caution amid the volatility, pointing to mixed signals like a major shareholder offloading shares and critical remarks from a co-founder about the company’s structure. There’s also intrigue around executive hints at a strategic roadmap and AI innovations, which have kept the conversation dynamic. The polarized views reflect a stock caught between bullish momentum and underlying risks.

Note: This discussion summary was generated from an AI condensation of post data.

Opendoor Technologies Congressional Stock Trading

Members of Congress have traded $OPEN stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $OPEN stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/19, 07/21 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Opendoor Technologies Insider Trading Activity

Opendoor Technologies insiders have traded $OPEN stock on the open market 12 times in the past 6 months. Of those trades, 4 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $OPEN stock by insiders over the last 6 months:

• ERIC CHUNG-WEI WU has made 2 purchases buying 751,879 shares for an estimated $4,999,995 and 0 sales.
• CARRIE WHEELER (Chief Executive Officer) sold 671,164 shares for an estimated $376,523
• SYDNEY SCHAUB (Chief Legal Officer) has made 0 purchases and 7 sales selling 176,098 shares for an estimated $201,571.
• SHRISHA RADHAKRISHNA (President) has made 2 purchases buying 30,000 shares for an estimated $128,339 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Opendoor Technologies Hedge Fund Activity

We have seen 100 institutional investors add shares of Opendoor Technologies stock to their portfolio, and 155 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. removed 35,718,664 shares (-70.2%) from their portfolio in Q2 2025, for an estimated $19,038,047
• VANGUARD GROUP INC removed 19,802,022 shares (-23.0%) from their portfolio in Q2 2025, for an estimated $10,554,477
• QUBE RESEARCH & TECHNOLOGIES LTD added 12,540,603 shares (+inf%) to their portfolio in Q2 2025, for an estimated $6,684,141
• TWO SIGMA ADVISERS, LP added 11,260,300 shares (+616.7%) to their portfolio in Q2 2025, for an estimated $6,001,739
• WEISS ASSET MANAGEMENT LP added 9,606,779 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,120,413
• STATE STREET CORP removed 9,431,110 shares (-64.7%) from their portfolio in Q2 2025, for an estimated $5,026,781
• VERITION FUND MANAGEMENT LLC added 9,060,735 shares (+inf%) to their portfolio in Q2 2025, for an estimated $4,829,371

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Opendoor Technologies Analyst Ratings

Wall Street analysts have issued reports on $OPEN in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Zelman & Assoc issued a "Underperform" rating on 08/07/2025
• Citigroup issued a "Sell" rating on 08/06/2025

To track analyst ratings and price targets for Opendoor Technologies, check out Quiver Quantitative's $OPEN forecast page.

Opendoor Technologies Price Targets

Multiple analysts have issued price targets for $OPEN recently. We have seen 4 analysts offer price targets for $OPEN in the last 6 months, with a median target of $1.0.

Here are some recent targets:

• Ryan Tomasello from Keefe, Bruyette & Woods set a target price of $1.0 on 08/13/2025
• An analyst from Zelman & Assoc set a target price of $1.0 on 08/07/2025
• Ygal Arounian from Citigroup set a target price of $0.7 on 08/06/2025
• Lloyd Walmsley from UBS set a target price of $1.6 on 08/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Pfizer Inc. (PFE) have been ignited by the company's landmark agreement with the U.S. government to slash drug prices by up to 85%, alongside positive trial data for a weight-loss drug. Many users are highlighting the stock's significant intraday jump of over 7% as a sign of market approval, while others are debating the long-term implications of this pricing strategy on profitability. The conversation reflects a mix of optimism and caution as investors weigh the benefits against potential regulatory challenges.

Additionally, posts on X have pointed to analyst commentary, with some viewing the deal as a positive catalyst for the pharmaceutical sector, while others remain skeptical about its broader impact. There's also chatter about Pfizer's reaffirmed commitment to vaccine safety and global health initiatives, which has sparked varied reactions among users. This development, paired with the stock's recent performance, continues to keep Pfizer at the forefront of investor discussions.

Note: This discussion summary was generated from an AI condensation of post data.

Pfizer Inc. Congressional Stock Trading

Members of Congress have traded $PFE stock 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 05/30, 04/29 and 1 sale worth up to $15,000 on 08/05.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/16 and 1 sale worth up to $15,000 on 08/04.
• SENATOR RON WYDEN sold up to $15,000 on 06/03.
• REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 06/03.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $50,000 on 05/15 and 1 sale worth up to $50,000 on 04/08.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Pfizer Inc. Hedge Fund Activity

We have seen 1,246 institutional investors add shares of Pfizer Inc. stock to their portfolio, and 1,454 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP removed 26,490,160 shares (-25.6%) from their portfolio in Q2 2025, for an estimated $642,121,478
• BLACKROCK, INC. added 20,709,704 shares (+4.4%) to their portfolio in Q2 2025, for an estimated $502,003,224
• AMUNDI removed 14,642,887 shares (-28.1%) from their portfolio in Q2 2025, for an estimated $354,943,580
• MARSHALL WACE, LLP removed 13,641,127 shares (-96.8%) from their portfolio in Q2 2025, for an estimated $330,660,918
• CAPITAL WORLD INVESTORS removed 13,368,274 shares (-49.1%) from their portfolio in Q2 2025, for an estimated $324,046,961
• QUBE RESEARCH & TECHNOLOGIES LTD removed 10,711,578 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $259,648,650
• VICTORY CAPITAL MANAGEMENT INC added 10,400,851 shares (+220.6%) to their portfolio in Q2 2025, for an estimated $252,116,628

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Pfizer Inc. Government Contracts

We have seen $1,715,709 of award payments to $PFE over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• STERILE WATER FOR INJECTION 20ML: $1,167,976
• PFIZER VACCINES STORAGE AND ROTATION CONTRACT: $410,203
• 4567359319!NALOXONE 4 MG/10 ML VIAL 10ML: $59,220
• 4568572944!NALOXONE 4 MG/10 ML VIAL 10ML: $11,280
• 4568676827!HEXTEND 6%-LACT ELEC BAG 500ML: $11,164

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Pfizer Inc. Price Targets

Multiple analysts have issued price targets for $PFE recently. We have seen 6 analysts offer price targets for $PFE in the last 6 months, with a median target of $25.5.

Here are some recent targets:

• Tim Anderson from B of A Securities set a target price of $28.0 on 08/06/2025
• Terence Flynn from Morgan Stanley set a target price of $33.0 on 08/06/2025
• Andrew Baum from Citigroup set a target price of $26.0 on 08/06/2025
• Trung Huynh from UBS set a target price of $25.0 on 04/30/2025
• Carter Gould from Cantor Fitzgerald set a target price of $24.0 on 04/22/2025
• Asad Haider from Goldman Sachs set a target price of $25.0 on 04/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about UnitedHealth Group (UNH) have centered on the company’s challenges, including regulatory scrutiny and financial pressures. Many users are highlighting a significant year-to-date decline in the stock price, with some pointing to ongoing Department of Justice investigations into Medicare billing practices as a key concern. The conversation reflects a tense atmosphere as investors grapple with the potential long-term impacts on the company’s performance.

Despite the negative focus, there are flickers of optimism in certain corners of X, with some users noting recent upgrades and high trading volumes as signs of potential recovery. Others have mentioned the company’s strategic moves in healthcare services and digital platforms as reasons for cautious hope. This mix of concern and faint positivity keeps the dialogue dynamic and closely watched by market participants.

Note: This discussion summary was generated from an AI condensation of post data.

UnitedHealth Group Congressional Stock Trading

Members of Congress have traded $UNH stock 39 times in the past 6 months. Of those trades, 17 have been purchases and 22 have been sales.

Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 4 times. They made 4 purchases worth up to $95,000 on 08/28, 08/04, 05/16, 05/14 and 0 sales.
• SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 08/28.
• REPRESENTATIVE TIM MOORE has traded it 5 times. They made 4 purchases worth up to $130,000 on 08/08, 08/01, 07/21, 07/16 and 1 sale worth up to $100,000 on 08/15.
• REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 08/14, 07/24, 04/07.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 08/13, 06/17 and 1 sale worth up to $15,000 on 06/24.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 05/30 and 2 sales worth up to $65,000 on 08/05, 04/29.
• SENATOR MARKWAYNE MULLIN sold up to $50,000 on 08/01.
• SENATOR ANGUS S. KING JR. sold up to $15,000 on 07/15.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 06/23.
• SENATOR JOHN BOOZMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 04/16 and 1 sale worth up to $15,000 on 06/11.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 05/15.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $50,000 on 04/08 and 1 sale worth up to $50,000 on 05/15.
• REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 05/14.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 04/07 and 1 sale worth up to $50,000 on 05/08.
• REPRESENTATIVE VAL T. HOYLE has traded it 3 times. They made 2 purchases worth up to $30,000 on 04/29, 04/15 and 1 sale worth up to $15,000 on 05/06.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 04/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

UnitedHealth Group Insider Trading Activity

UnitedHealth Group insiders have traded $UNH stock on the open market 7 times in the past 6 months. Of those trades, 5 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $UNH stock by insiders over the last 6 months:

• STEPHEN J HEMSLEY (CEO, UHG) purchased 86,700 shares for an estimated $25,019,019
• JOHN F REX (President & CFO) purchased 17,175 shares for an estimated $4,999,919
• KRISTEN GIL purchased 3,700 shares for an estimated $1,003,329
• TIMOTHY PATRICK FLYNN purchased 1,533 shares for an estimated $491,786
• PATRICK HUGH CONWAY (Chief Executive Officer, Optum) sold 589 shares for an estimated $179,645
• JOHN H NOSEWORTHY purchased 300 shares for an estimated $93,646
• CHARLES D. BAKER sold 27 shares for an estimated $9,613

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UnitedHealth Group Hedge Fund Activity

We have seen 1,490 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 2,035 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS removed 15,078,082 shares (-72.4%) from their portfolio in Q2 2025, for an estimated $4,703,909,241
• GAMMA INVESTING LLC removed 8,283,184 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $2,584,104,912
• FMR LLC removed 7,414,111 shares (-30.6%) from their portfolio in Q2 2025, for an estimated $2,312,980,208
• JPMORGAN CHASE & CO removed 6,297,614 shares (-24.0%) from their portfolio in Q2 2025, for an estimated $1,964,666,639
• MORGAN STANLEY removed 6,262,215 shares (-29.3%) from their portfolio in Q2 2025, for an estimated $1,953,623,213
• BERKSHIRE HATHAWAY INC added 5,039,564 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,572,192,781
• DODGE & COX added 4,730,192 shares (+117.7%) to their portfolio in Q2 2025, for an estimated $1,475,677,998

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UnitedHealth Group Government Contracts

We have seen $16,809,868,983 of award payments to $UNH over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• EXPRESS REPORT: R3 FY25 3RD QTR APRIL: $830,362,703
• EXPRESS REPORT: R3 FY25 3RD QTR MAY: $819,320,444
• EXPRESS REPORT: R3 FY25 2ND QTR MARCH: $791,841,212
• EXPRESS REPORT: R3 FY25 1ST QTR OCTOBER: $771,731,035
• EXPRESS REPORT: R3 FY25 1ST QTR NOVEMBER: $749,361,473

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

UnitedHealth Group Analyst Ratings

Wall Street analysts have issued reports on $UNH in the last several months. We have seen 15 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 09/12/2025
• Truist Securities issued a "Buy" rating on 09/09/2025
• Cantor Fitzgerald issued a "Overweight" rating on 08/26/2025
• JP Morgan issued a "Overweight" rating on 08/06/2025
• Baird issued a "Underperform" rating on 07/31/2025
• Piper Sandler issued a "Overweight" rating on 07/30/2025
• Keybanc issued a "Overweight" rating on 07/30/2025

To track analyst ratings and price targets for UnitedHealth Group, check out Quiver Quantitative's $UNH forecast page.

UnitedHealth Group Price Targets

Multiple analysts have issued price targets for $UNH recently. We have seen 21 analysts offer price targets for $UNH in the last 6 months, with a median target of $350.0.

Here are some recent targets:

• Ricky Goldwasser from Morgan Stanley set a target price of $395.0 on 09/12/2025
• David Macdonald from Truist Securities set a target price of $365.0 on 09/09/2025
• Lance Wilkes from Bernstein set a target price of $379.0 on 09/05/2025
• Andrew Mok from Barclays set a target price of $352.0 on 09/04/2025
• Sarah James from Cantor Fitzgerald set a target price of $440.0 on 08/26/2025
• Kevin Fischbeck from B of A Securities set a target price of $325.0 on 08/18/2025
• Lisa Gill from JP Morgan set a target price of $310.0 on 08/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Alphabet Inc. (GOOG) have centered around the company's strategic advancements in AI and cloud services, sparking a lively conversation among investors and tech enthusiasts. A reported multi-billion-dollar cloud deal with a major tech player has fueled optimism, with many highlighting Alphabet's potential to dominate in this high-growth sector. The integration of AI technologies into existing products is also seen as a significant driver of future revenue by several users.

However, not all sentiments are uniformly positive, as some on X express concerns over regulatory challenges and competitive pressures in the AI and search markets. Discussions also touch on recent stock price fluctuations, with a mix of opinions on whether the current trajectory reflects Alphabet's long-term potential. The dynamic nature of these conversations underscores the intense interest in Alphabet's next moves amidst a rapidly evolving tech landscape.

Note: This discussion summary was generated from an AI condensation of post data.

Alphabet Inc. Congressional Stock Trading

Members of Congress have traded $GOOG stock 34 times in the past 6 months. Of those trades, 24 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $GOOG stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 12 times. They made 12 purchases worth up to $1,715,000 on 09/17, 09/03, 08/01, 07/30, 07/29, 07/17, 07/14, 06/25, 06/05 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 4 times. They made 4 purchases worth up to $60,000 on 09/11, 08/28, 05/14, 05/05 and 0 sales.
• REPRESENTATIVE SCOTT FRANKLIN sold up to $15,000 on 06/16.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/11, 06/09 and 1 sale worth up to $15,000 on 06/10.
• REPRESENTATIVE JOHN W. ROSE sold up to $500,000 on 06/03.
• SENATOR JOHN FETTERMAN purchased up to $15,000 on 05/15.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $250,000 on 05/12.
• SENATOR JERRY MORAN has traded it 4 times. They made 4 purchases worth up to $60,000 on 05/08 and 0 sales.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 05/08, 04/09.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 4 times. They made 1 purchase worth up to $15,000 on 04/11 and 3 sales worth up to $45,000 on 05/08, 05/07, 04/08.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Alphabet Inc. Hedge Fund Activity

We have seen 1,973 institutional investors add shares of Alphabet Inc. stock to their portfolio, and 1,932 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 135,064,454 shares (+580897.4%) to their portfolio in Q2 2025, for an estimated $23,959,083,495
• GAMMA INVESTING LLC removed 14,224,063 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $2,523,206,535
• NUVEEN, LLC added 12,693,714 shares (+75.6%) to their portfolio in Q2 2025, for an estimated $2,251,737,926
• BANK OF NEW YORK MELLON CORP removed 11,096,086 shares (-26.3%) from their portfolio in Q2 2025, for an estimated $1,968,334,695
• JPMORGAN CHASE & CO removed 10,607,689 shares (-10.4%) from their portfolio in Q2 2025, for an estimated $1,881,697,951
• JANUS HENDERSON GROUP PLC removed 9,128,861 shares (-29.4%) from their portfolio in Q2 2025, for an estimated $1,619,368,652
• CAPITAL RESEARCH GLOBAL INVESTORS removed 8,737,186 shares (-24.1%) from their portfolio in Q2 2025, for an estimated $1,549,889,424

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Alphabet Inc. Analyst Ratings

Wall Street analysts have issued reports on $GOOG in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Overweight" rating on 09/03/2025
• Oppenheimer issued a "Outperform" rating on 09/03/2025
• Raymond James issued a "Outperform" rating on 07/24/2025
• Scotiabank issued a "Sector Outperform" rating on 07/22/2025
• WestPark Capital issued a "Buy" rating on 04/25/2025
• Keybanc issued a "Overweight" rating on 04/09/2025

To track analyst ratings and price targets for Alphabet Inc., check out Quiver Quantitative's $GOOG forecast page.

Alphabet Inc. Price Targets

Multiple analysts have issued price targets for $GOOG recently. We have seen 7 analysts offer price targets for $GOOG in the last 6 months, with a median target of $210.0.

Here are some recent targets:

• Jason Helfstein from Oppenheimer set a target price of $270.0 on 09/03/2025
• Doug Anmuth from JP Morgan set a target price of $260.0 on 09/03/2025
• Josh Beck from Raymond James set a target price of $210.0 on 07/24/2025
• Nat Schindler from Scotiabank set a target price of $240.0 on 07/22/2025
• Lloyd Walmsley from UBS set a target price of $192.0 on 07/16/2025
• Curtis Shauger from WestPark Capital set a target price of $210.0 on 04/25/2025
• Justin Patterson from Keybanc set a target price of $185.0 on 04/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent discussions on X about Amazon (AMZN) have been lively, focusing heavily on the company's performance in cloud computing through Amazon Web Services (AWS) and its aggressive investments in artificial intelligence. Many users are buzzing about the potential for AWS growth to reaccelerate, with some expressing optimism over analyst upgrades and price targets suggesting significant upside. However, there’s also a notable undercurrent of concern regarding near-term pressures from high capital expenditures.

The conversation on X also reflects a split in perspectives on Amazon’s stock trajectory, with some highlighting strong fundamentals like e-commerce margins and advertising growth as reasons for confidence. Others caution about macro headwinds and recent price stagnation, pointing to technical breakdowns and resistance levels as potential warning signs. This dynamic debate keeps the platform abuzz with speculation on whether Amazon’s long-term vision will outweigh short-term challenges.

Note: This discussion summary was generated from an AI condensation of post data.

Amazon Congressional Stock Trading

Members of Congress have traded $AMZN stock 41 times in the past 6 months. Of those trades, 31 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 16 times. They made 16 purchases worth up to $2,915,000 on 09/17, 09/10, 09/03, 08/15, 08/01, 07/29, 07/16, 07/14, 06/30, 06/25, 06/09, 06/05 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 06/17, 06/09 and 2 sales worth up to $30,000 on 08/04, 07/22.
• REPRESENTATIVE VAL T. HOYLE has traded it 3 times. They made 3 purchases worth up to $45,000 on 07/02, 06/06, 04/02 and 0 sales.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 1 purchase worth up to $15,000 on 04/08 and 2 sales worth up to $30,000 on 06/23, 04/03.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 05/16.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $500,000 on 05/12.
• REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/08, 04/24 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/05, 04/08, 04/04 and 0 sales.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 04/29.
• REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 1 purchase worth up to $15,000 on 04/23 and 1 sale worth up to $50,000 on 04/16.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
• REPRESENTATIVE JULIE JOHNSON sold up to $50,000 on 04/07.
• REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Amazon Insider Trading Activity

Amazon insiders have traded $AMZN stock on the open market 66 times in the past 6 months. Of those trades, 0 have been purchases and 66 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by insiders over the last 6 months:

• JEFFREY P BEZOS (Executive Chair) has made 0 purchases and 22 sales selling 25,000,000 shares for an estimated $5,654,270,933.
• DAVID ZAPOLSKY (Senior Vice President) has made 0 purchases and 8 sales selling 41,340 shares for an estimated $8,771,239.
• ANDREW R JASSY (President and CEO) has made 0 purchases and 5 sales selling 39,744 shares for an estimated $8,403,578.
• MATTHEW S GARMAN (CEO Amazon Web Services) has made 0 purchases and 6 sales selling 38,708 shares for an estimated $8,152,467.
• DOUGLAS J HERRINGTON (CEO Worldwide Amazon Stores) has made 0 purchases and 18 sales selling 35,746 shares for an estimated $7,621,508.
• BRIAN T OLSAVSKY (Senior Vice President and CFO) has made 0 purchases and 2 sales selling 35,500 shares for an estimated $7,531,502.
• SHELLEY REYNOLDS (Vice President) has made 0 purchases and 4 sales selling 5,410 shares for an estimated $1,142,883.
• KEITH BRIAN ALEXANDER sold 1,000 shares for an estimated $210,680

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Amazon Hedge Fund Activity

We have seen 2,980 institutional investors add shares of Amazon stock to their portfolio, and 2,076 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 132,616,953 shares (+542733.6%) to their portfolio in Q2 2025, for an estimated $29,094,833,318
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 69,080,235 shares (+781.6%) to their portfolio in Q2 2025, for an estimated $15,155,512,756
• GAMMA INVESTING LLC removed 30,063,218 shares (-99.4%) from their portfolio in Q2 2025, for an estimated $6,595,569,397
• INFINITUM ASSET MANAGEMENT, LLC removed 23,657,500 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $5,190,218,925
• VANGUARD GROUP INC added 17,447,045 shares (+2.1%) to their portfolio in Q2 2025, for an estimated $3,827,707,202
• PRICE T ROWE ASSOCIATES INC /MD/ removed 17,284,407 shares (-9.8%) from their portfolio in Q2 2025, for an estimated $3,792,026,051
• CAPITAL WORLD INVESTORS removed 16,381,890 shares (-24.7%) from their portfolio in Q2 2025, for an estimated $3,594,022,847

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Amazon Analyst Ratings

Wall Street analysts have issued reports on $AMZN in the last several months. We have seen 33 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 09/30/2025
• Wells Fargo issued a "Overweight" rating on 09/24/2025
• Telsey Advisory Group issued a "Outperform" rating on 09/24/2025
• Truist Securities issued a "Buy" rating on 09/16/2025
• Morgan Stanley issued a "Overweight" rating on 08/14/2025
• Evercore ISI Group issued a "Outperform" rating on 08/13/2025
• WestPark Capital issued a "Buy" rating on 08/01/2025

To track analyst ratings and price targets for Amazon, check out Quiver Quantitative's $AMZN forecast page.

Amazon Price Targets

Multiple analysts have issued price targets for $AMZN recently. We have seen 36 analysts offer price targets for $AMZN in the last 6 months, with a median target of $265.0.

Here are some recent targets:

• Lloyd Walmsley from Mizuho set a target price of $300.0 on 09/30/2025
• Joseph Feldman from Telsey Advisory Group set a target price of $265.0 on 09/24/2025
• Ken Gawrelski from Wells Fargo set a target price of $280.0 on 09/24/2025
• Scott Devitt from Wedbush set a target price of $250.0 on 09/19/2025
• Youssef Squali from Truist Securities set a target price of $270.0 on 09/16/2025
• Brian Nowak from Morgan Stanley set a target price of $300.0 on 08/14/2025
• Mark Mahaney from Evercore ISI Group set a target price of $280.0 on 08/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$20,000 of HNI CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Shared information regarding the scope of products HNI manufactures and our manufacturing footprint. Broadly shared information on how tariffs may impact our operations. Discussed the potential impact of New Source Performance Standards for wood heaters, a new federal reference method for testing those products, and overall impact of these regulations on our residential building products division. Emphasized the need for manufacturer input and that any changes will require our company to redesign products, additional testing and compliance efforts. Urged adoption of realistic emissions standards that manufacturers can meet with an appropriate transition period. Notified lawmakers about the repeal of the Biomass Tax Credit retaining the Biomass Tax Credit, a piece of the Energy Efficient Home Improvement Tax Credit/25C. Explained how loss of the tax credit hurts the market for wood heaters, and our dealers who sell them."

You can find more data on corporate lobbying on Quiver Quantitative.

HNI Congressional Stock Trading

Members of Congress have traded $HNI stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $HNI stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HNI Insider Trading Activity

HNI insiders have traded $HNI stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $HNI stock by insiders over the last 6 months:

• MIGUEL M CALADO has made 0 purchases and 2 sales selling 3,743 shares for an estimated $192,379.
• JASON DEAN HAGEDORN (President, Allsteel LLC) sold 1,440 shares for an estimated $67,780
• JEFFREY D LORENGER (President & CEO) has made 0 purchases and 2 sales selling 200 shares for an estimated $10,658.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HNI Hedge Fund Activity

We have seen 112 institutional investors add shares of HNI stock to their portfolio, and 136 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ADAGE CAPITAL PARTNERS GP, L.L.C. added 872,000 shares (+348.8%) to their portfolio in Q2 2025, for an estimated $42,884,960
• BLACKROCK, INC. removed 508,444 shares (-6.9%) from their portfolio in Q2 2025, for an estimated $25,005,275
• ROYAL BANK OF CANADA added 349,776 shares (+4047.4%) to their portfolio in Q2 2025, for an estimated $17,201,983
• SG CAPITAL MANAGEMENT LLC removed 264,829 shares (-65.9%) from their portfolio in Q2 2025, for an estimated $13,024,290
• JONES FINANCIAL COMPANIES LLLP removed 234,098 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $11,512,939
• PENN CAPITAL MANAGEMENT COMPANY, LLC added 180,145 shares (+inf%) to their portfolio in Q2 2025, for an estimated $8,859,531
• CERITY PARTNERS LLC removed 168,107 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $8,267,502

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HNI Analyst Ratings

Wall Street analysts have issued reports on $HNI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Longbow Research issued a "Buy" rating on 05/16/2025

To track analyst ratings and price targets for HNI, check out Quiver Quantitative's $HNI forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of REGENERON PHARMACEUTICALS INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Biodefense funding"

You can find more data on corporate lobbying on Quiver Quantitative.

REGN Congressional Stock Trading

Members of Congress have traded $REGN stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $REGN stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 05/15 and 1 sale worth up to $15,000 on 04/08.
• REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/10.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

REGN Hedge Fund Activity

We have seen 553 institutional investors add shares of REGN stock to their portfolio, and 663 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 4,271,533 shares (-56.2%) from their portfolio in Q2 2025, for an estimated $2,242,554,825
• JPMORGAN CHASE & CO removed 1,718,579 shares (-30.4%) from their portfolio in Q2 2025, for an estimated $902,253,975
• DODGE & COX added 1,502,198 shares (+64.6%) to their portfolio in Q2 2025, for an estimated $788,653,950
• PRICE T ROWE ASSOCIATES INC /MD/ removed 1,408,582 shares (-64.8%) from their portfolio in Q2 2025, for an estimated $739,505,550
• CAPITAL INTERNATIONAL INVESTORS removed 823,869 shares (-20.7%) from their portfolio in Q2 2025, for an estimated $432,531,225
• GAMMA INVESTING LLC removed 814,345 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $427,531,125
• AMUNDI removed 706,770 shares (-44.1%) from their portfolio in Q2 2025, for an estimated $371,054,250

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

REGN Analyst Ratings

Wall Street analysts have issued reports on $REGN in the last several months. We have seen 11 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 08/04/2025
• Canaccord Genuity issued a "Buy" rating on 07/23/2025
• JP Morgan issued a "Overweight" rating on 06/09/2025
• Morgan Stanley issued a "Overweight" rating on 06/02/2025
• Citigroup issued a "Buy" rating on 06/02/2025
• RBC Capital issued a "Outperform" rating on 05/27/2025
• Guggenheim issued a "Buy" rating on 05/01/2025

To track analyst ratings and price targets for REGN, check out Quiver Quantitative's $REGN forecast page.

REGN Price Targets

Multiple analysts have issued price targets for $REGN recently. We have seen 17 analysts offer price targets for $REGN in the last 6 months, with a median target of $761.0.

Here are some recent targets:

• William Pickering from Bernstein set a target price of $781.0 on 08/27/2025
• Akash Tewari from Jefferies set a target price of $831.0 on 08/27/2025
• Srikripa Devarakonda from Truist Securities set a target price of $812.0 on 08/11/2025
• Brian Abrahams from RBC Capital set a target price of $695.0 on 08/04/2025
• Matthew Harrison from Morgan Stanley set a target price of $761.0 on 08/04/2025
• Evan David Seigerman from BMO Capital set a target price of $640.0 on 08/04/2025
• Yatin Suneja from Guggenheim set a target price of $815.0 on 08/04/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$80,000 of SIGA TECHNOLOGIES lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Biodefense funding"

You can find more data on corporate lobbying on Quiver Quantitative.

SIGA Hedge Fund Activity

We have seen 96 institutional investors add shares of SIGA stock to their portfolio, and 72 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 1,090,560 shares (-34.5%) from their portfolio in Q2 2025, for an estimated $7,110,451
• FIRST WILSHIRE SECURITIES MANAGEMENT INC removed 889,640 shares (-56.1%) from their portfolio in Q2 2025, for an estimated $5,800,452
• JACOBS LEVY EQUITY MANAGEMENT, INC added 438,854 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,861,328
• CSM ADVISORS, LLC added 358,257 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,335,835
• BANK OF AMERICA CORP /DE/ added 238,869 shares (+143.2%) to their portfolio in Q2 2025, for an estimated $1,557,425
• GOLDMAN SACHS GROUP INC added 238,411 shares (+84.2%) to their portfolio in Q2 2025, for an estimated $1,554,439
• CITADEL ADVISORS LLC added 233,682 shares (+20.1%) to their portfolio in Q2 2025, for an estimated $1,523,606

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of GOOGLE CLIENT SERVICES LLC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"competition issues patent legislation online privacy, safety issues"

You can find more data on corporate lobbying on Quiver Quantitative.

GOOGL Congressional Stock Trading

Members of Congress have traded $GOOGL stock 21 times in the past 6 months. Of those trades, 9 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 09/03.
• SENATOR SHELLEY MOORE CAPITO has traded it 3 times. They made 3 purchases worth up to $45,000 on 07/29, 05/08, 04/29 and 0 sales.
• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
• REPRESENTATIVE VAL T. HOYLE has traded it 4 times. They made 2 purchases worth up to $30,000 on 07/14, 07/02 and 2 sales worth up to $30,000 on 04/15, 04/02.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/24.
• REPRESENTATIVE JOHN W. ROSE sold up to $5,000,000 on 06/03.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 05/20.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $250,000 on 05/12.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
• REPRESENTATIVE JONATHAN L. JACKSON sold up to $50,000 on 04/21.
• SENATOR TOMMY TUBERVILLE sold up to $50,000 on 04/15.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
• REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GOOGL Insider Trading Activity

GOOGL insiders have traded $GOOGL stock on the open market 110 times in the past 6 months. Of those trades, 0 have been purchases and 110 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by insiders over the last 6 months:

• SUNDAR PICHAI (Chief Executive Officer) has made 0 purchases and 63 sales selling 390,000 shares for an estimated $72,317,606.
• KAVITARK RAM SHRIRAM has made 0 purchases and 4 sales selling 59,566 shares for an estimated $11,565,220.
• JOHN KENT WALKER (President, Global Affairs, CLO) sold 23,820 shares for an estimated $4,637,754
• JOHN L. HENNESSY has made 0 purchases and 35 sales selling 4,000 shares for an estimated $784,712.
• AMIE THUENER O'TOOLE (VP, Chief Accounting Officer) sold 2,778 shares for an estimated $680,610
• FRANCES ARNOLD has made 0 purchases and 6 sales selling 649 shares for an estimated $124,813.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GOOGL Hedge Fund Activity

We have seen 2,440 institutional investors add shares of GOOGL stock to their portfolio, and 2,097 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GAMMA INVESTING LLC removed 15,944,572 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $2,809,911,923
• PRICE T ROWE ASSOCIATES INC /MD/ removed 14,910,314 shares (-16.7%) from their portfolio in Q2 2025, for an estimated $2,627,644,636
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 11,522,921 shares (+26.3%) to their portfolio in Q2 2025, for an estimated $2,030,684,367
• FRANKLIN RESOURCES INC added 10,843,853 shares (+51.7%) to their portfolio in Q2 2025, for an estimated $1,911,012,214
• CAPITAL RESEARCH GLOBAL INVESTORS removed 10,062,090 shares (-18.7%) from their portfolio in Q2 2025, for an estimated $1,773,242,120
• WELLINGTON MANAGEMENT GROUP LLP added 10,042,091 shares (+17.9%) to their portfolio in Q2 2025, for an estimated $1,769,717,696
• BLACKROCK, INC. removed 9,367,765 shares (-2.1%) from their portfolio in Q2 2025, for an estimated $1,650,881,225

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GOOGL Analyst Ratings

Wall Street analysts have issued reports on $GOOGL in the last several months. We have seen 23 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 09/30/2025
• MoffettNathanson issued a "Buy" rating on 09/25/2025
• Truist Securities issued a "Buy" rating on 09/22/2025
• Piper Sandler issued a "Overweight" rating on 09/18/2025
• Citigroup issued a "Buy" rating on 09/15/2025
• Evercore ISI Group issued a "Outperform" rating on 09/08/2025
• Tigress Financial issued a "Strong Buy" rating on 09/05/2025

To track analyst ratings and price targets for GOOGL, check out Quiver Quantitative's $GOOGL forecast page.

GOOGL Price Targets

Multiple analysts have issued price targets for $GOOGL recently. We have seen 34 analysts offer price targets for $GOOGL in the last 6 months, with a median target of $228.5.

Here are some recent targets:

• Lloyd Walmsley from Mizuho set a target price of $295.0 on 09/30/2025
• Michael Nathanson from MoffettNathanson set a target price of $295.0 on 09/25/2025
• Deepak Mathivanan from Cantor Fitzgerald set a target price of $201.0 on 09/24/2025
• Youssef Squali from Truist Securities set a target price of $285.0 on 09/22/2025
• Colin Sebastian from Baird set a target price of $275.0 on 09/22/2025
• Andrew Boone from JMP Securities set a target price of $290.0 on 09/19/2025
• Thomas Champion from Piper Sandler set a target price of $285.0 on 09/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of DAVITA lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Dialysis services, HR3944 - military construction, Veterans Affairs, and related agencies appropriations Act"

You can find more data on corporate lobbying on Quiver Quantitative.

DVA Insider Trading Activity

DVA insiders have traded $DVA stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:

• HATHAWAY INC BERKSHIRE has made 0 purchases and 10 sales selling 2,981,900 shares for an estimated $426,370,810.
• JAMES O HEARTY (Chief Compliance Officer) sold 2,351 shares for an estimated $352,650

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DVA Hedge Fund Activity

We have seen 244 institutional investors add shares of DVA stock to their portfolio, and 298 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BERKSHIRE HATHAWAY INC removed 1,345,938 shares (-3.8%) from their portfolio in Q2 2025, for an estimated $191,728,868
• PACER ADVISORS, INC. added 456,285 shares (+4437.7%) to their portfolio in Q2 2025, for an estimated $64,997,798
• HOLOCENE ADVISORS, LP removed 409,638 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $58,352,933
• EPOCH INVESTMENT PARTNERS, INC. removed 399,500 shares (-97.9%) from their portfolio in Q2 2025, for an estimated $56,908,774
• GATES CAPITAL MANAGEMENT, INC. added 376,775 shares (+52.2%) to their portfolio in Q2 2025, for an estimated $53,671,598
• IRON TRIANGLE PARTNERS LP removed 319,566 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $45,522,176
• VANGUARD GROUP INC removed 306,538 shares (-6.1%) from their portfolio in Q2 2025, for an estimated $43,666,338

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DVA Analyst Ratings

Wall Street analysts have issued reports on $DVA in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Underperform" rating on 09/10/2025

To track analyst ratings and price targets for DVA, check out Quiver Quantitative's $DVA forecast page.

DVA Price Targets

Multiple analysts have issued price targets for $DVA recently. We have seen 3 analysts offer price targets for $DVA in the last 6 months, with a median target of $160.0.

Here are some recent targets:

• Kevin Fischbeck from B of A Securities set a target price of $140.0 on 09/10/2025
• Andrew Mok from Barclays set a target price of $160.0 on 08/07/2025
• David Macdonald from Truist Securities set a target price of $164.0 on 05/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of KIRBY CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Energy & Water Appropriations for FY2025 and FY2026. Opposing changes to the Merchant Marine Act of 1920; and Marine safety issues in the upcoming Coast Guard Authorization Act."

You can find more data on corporate lobbying on Quiver Quantitative.

KEX Congressional Stock Trading

Members of Congress have traded $KEX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $KEX stock by members of Congress over the last 6 months:

• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

KEX Hedge Fund Activity

We have seen 206 institutional investors add shares of KEX stock to their portfolio, and 193 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ALLIANCEBERNSTEIN L.P. added 959,209 shares (+72.5%) to their portfolio in Q2 2025, for an estimated $108,783,892
• HOOD RIVER CAPITAL MANAGEMENT LLC added 650,595 shares (+inf%) to their portfolio in Q2 2025, for an estimated $73,783,978
• ENCOMPASS CAPITAL ADVISORS LLC added 299,981 shares (+32.4%) to their portfolio in Q2 2025, for an estimated $34,020,845
• WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 289,370 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,817,451
• VANGUARD GROUP INC removed 255,962 shares (-4.4%) from their portfolio in Q2 2025, for an estimated $29,028,650
• JENNISON ASSOCIATES LLC removed 254,429 shares (-19.6%) from their portfolio in Q2 2025, for an estimated $28,854,792
• CITADEL ADVISORS LLC added 234,300 shares (+249.2%) to their portfolio in Q2 2025, for an estimated $26,571,963

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

KEX Analyst Ratings

Wall Street analysts have issued reports on $KEX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 09/18/2025
• B of A Securities issued a "Buy" rating on 09/03/2025

To track analyst ratings and price targets for KEX, check out Quiver Quantitative's $KEX forecast page.

KEX Price Targets

Multiple analysts have issued price targets for $KEX recently. We have seen 3 analysts offer price targets for $KEX in the last 6 months, with a median target of $107.0.

Here are some recent targets:

• Ben Mohr from Citigroup set a target price of $91.0 on 09/22/2025
• Gregory Lewis from BTIG set a target price of $125.0 on 09/18/2025
• Ken Hoexter from B of A Securities set a target price of $107.0 on 09/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.